





Response of Endothelial Cells to exposure to 
Chlamydia trachomatis, biovar LGV. 
 
 
Ikanyeng Dolly Seipone 
 
 
Submitted in fulfilment of the requirements for the degree of Master of 
Medical Science (Medical Microbiology) in the Department of Infection 













































                          I, Ikanyeng Dolly Seipone declare that 
 
(i) The research reported in this dissertation, except where otherwise indicated, is my 
original work 
 
(ii) This dissertation has not been submitted for any degree or examination at any 
other university. 
 
(iii) This dissertation does not contain other person’s data, pictures, graphs or other 
information, unless specifically acknowledged as being sourced from other persons. 
 
(iv) This dissertation does not contain other person’s writing, unless specifically 
acknowledged as being sourced from other researchers. Where other written sources 
have been quoted, then: 
a) Their words have been rewritten but the general information attributed to 
them has been referenced; 
b) Where their exact words have been used, their writing has been placed 
inside quotation marks, and referenced. 
 
(v) Where I have reproduced a publication of which I am an author, co-author or 
editor, I have indicated in detail which part of the publication was actually written by 
myself alone and have fully referenced such publications. 
 
(vi) This dissertation does not contain text, graphics or tables copied and pasted from 
the Internet, unless specifically acknowledged, and the source being detailed in the 














PRESENTATIONS FROM THIS THESIS 
 
 
I.D. Seipone and A.W. Sturm. 2008. Comparison of the effect of Chlamydia 
trachomatis strains (Lymphogranuloma Venereum and Ocular genital) in/on 
endothelial cells. 
-11th International Union against Sexually Transmitted Infections (IUSTI)  
























This dissertation is dedicated to my dad, Kgosi C.P. Seipone. I am where I am 
because of the way you raised me up. Thanks for the values and morals you instilled 
in me and raising me up to believe that I can be everything that I want to be. May God 

























To my supervisor Professor A.W.  Sturm, thank you for your advice, guidance and 
support throughout the years and allowing me the opportunity to grow as a scientist, it 
was an honor to work with you.  I have learnt a lot from you.  
 
I owe my deepest gratitude to my family, dad Kgosi C.P. Seipone, to all my sisters 
(Kefilwe, Tebogo, Nametsegang, Tshepiso and my twin sister Tiny), thank you guys 
for allowing me to spread my wings and fly and for believing in me. Your love and 
support kept me going. 
 
To the staff of the Department of Infection Prevention and Control, thank you for the 
assistance, it has been a pleasure working with you. 
 
My gratitude goes to Dr. Bronwyn Joubert for the help and input she had towards 
completing this project. Thank you for being patient in answering my never ending 
questions. 
 
Thank you to Professor T.  Naicker and the Department of Optics and Imaging for the 
fluorescent microscope. 
 
To my fellow postgraduates students, Bongiwe Ndimande, Olubisi Ashiru, Relebohile 
Moeketsi, Lindo Ndlandla, Nhlanhla Jwara and Zama Msibi and to all my friends, 
Tshediso Moloi, Zime Ngcobo, Siyanela Dlamini, Mthokozisi Cele, Maina Andrick 
and all the others that I did not mention, thanks for the encouragement, help and 
support. 
 
Thanks to the DST/AFRICA scholarship managed by the National Research 
Foundation for the two years of financial support, and also to the department of 
Infection Prevention and Control for their financial assistance 
 
Last but not least, I want to thank God Almighty for making this possible, all glory 




TABLE OF CONTENTS 
 
LIST OF ABBREVIATIONS vii 
  
LIST OF FIGURES xi 
  
LIST OF TABLES xiii 
  






3 CHAPTER 1: INTRODUCTION 
  
 CHAPTER 2: LITERATURE REVIEW  
2.1 
2.1.1 Classification 
Chlamydia trachomatis   
6 
2.1.2 Characteristics and Morphology 6 
2.1.3 Life-Cycle of Chlamydia trachomatis 7 
2.1.4 Biovars and serovars of Chlamydia trachomatis 8 
2.1.5 Chlamydia infections  
2.1.5.1 Lymphogranuloma Venereum 9 
 ii 
2.1.5.2 Urogenital  10 
2.1.5.3 Trachoma 10 
2.1.6 Epidiemology of Chlamydia trachomatis infections 11 
2.1.7 Laboratory detection of Chlamydia trachomatis 12 
2.1.8 Treatment of Chlamydia infections 13 
  
13 2.2 CHEMOKINES AND CELL ADHESION MOLECULES 
2.2.1 Interleukin-8 14 
2.2.2 Monocyte Chemotactic Protein-1 16 
2.2.3 Intercellular Cell Adhesion Molecule-1 17 
19 2.3 ENDOTHELIAL CELLS 
  
20 2.4 EXTRAVASATION/ TRANSENDOTHELIAL MIGRATION 
  
 2.5 INTERACTION OF CHLAMYDIA WITH ENDOTHELIAL 
CELLS 
2.5.1 Production of Chemokines and Adhesion molecules 23 
2.5.2 Transendothelial migration of neutrophils and monocytes 24 
  
 2.6 CELL DEATH  
2.6.1 Overview 25 
2.6.2. Apoptosis 26 
2.6.3 Necrosis 27 
2.6.4 Oncosis 28 
2.6.5 Autophagy 28 
 iii 
2.6.6 Pyroptosis 29 
2.6.7 Measurement of Cell death 29 
2.6.8 Chlamydia induced Cell death 31 
  
 CHAPTER 3: MATERIALS AND METHODS 
34 3.1. CELL CULTURES AND PROPAGATION OF ISOLATES  
3.1.1 McCoy Cells  
3.1.1.1. Reconstitution  34 
3.1.1.2 Trypsinization 35 
3.1.1.3 Cell count 36 
3.1.1.4 Propagation of McCoy cells 36 
3.1.2 Chlamydial serovars  
2.1.2.1 Inoculation 37 
2.1.2.2 Harvesting of chlamydia 38 
2.1.2.3 Determination of inclusion body concentration 39 
3.1.3 Endothelial Cell cultures  
3.1.3.1 Propagation 40 
3.1.3.2 Subculturing of HUVEC  41 
  
 3.2 CHEMOKINE AND ADHESION MOLECULE ASSAYS 
3.2.1 Infection protocol 42 
3.2.2 Monocyte Chemotactic Protein-1 ELISA 43 
3.2.3 Interleukin-8 ELISA  44 
3.2.4 Cell surface Intercellular Cell Adhesion Molecule-1 ELISA 44 
3.2.5 Calculation of Results  45 
 iv 
  
46 3.3 TRANSENDOTHELIAL MIGRATION ASSAY 
3.3.1 Silver Nitrate staining 46 
3.3.2 Infection protocol 47 
3.3.3 Isolation of human neutrophils and monocytes 47 
3.3.4 Transendothelial migration assay 49 
  
 3.4 LACTATE DEHYDROGENASE RELEASE CYTOTOXICITY 
ASSAY 
3.4.1 Infection protocol 50 
3.4.2 Lactate Dehydrogenase Release Assay 50 
3.4.3 Calculation of Results 52 
  
52 3.5 STATISTICAL ANALYSIS 
  
52 3.6 APOPTOSIS ASSAYS 
3.6.1 CaspGLOWTM Flourescein Caspase Staining Assay 53 
3.6.1.1 Infection protocol 53 
3.6.1.2 Analysis of Cell death 54 
3.6.2 DeadEndTM Colorimetric TUNEL System Assay 54 
3.6.2.1 Infection protocol 55 
3.6.2.2 Analysis of Cell death 55 
  
  
58 CHAPTER 4: RESULTS 
 v 
58 4.1 Infection of HUVEC with chlamydial serovars 
  
 4.2 Chemokines and Adhesion Molecules Assays 
4.2.1 Chemokines (IL-8 and MCP-1) stimulation by C. trachomatis  59 
infected HUVEC  
4.2.2 Adhesion molecule (ICAM-1) stimulation on C. trachomatis  60 
infected HUVEC  
  
62 4.3. Transendothelial migration assay 
  
64 4.4. Cytotoxicity assay 
  
 4.5 Apoptosis assay 
4.5.1 DeadEndTM Colorimetric TUNEL System Assay 65 
4.5.2 CaspGLOWTM Flourescein Caspase Staining Assay 69 
  
71 CHAPTER 5: DISCUSSION 
  




APPENDIX A - Tissue culture reagents and media 99 
  
APPENDIX B - Objective lens Conversion factors 102 
 vi 
  
APPENDIX C - Preparation of Reagents for ELISA 103 
  
APPENDIX D - Raw data from experiments 106 
  
























LIST OF ABBREVIATIONS 
 
ATCC   
 










C. trachomatis  
C. pneumoniae   














analysis of variance 
B-cell lymphocytic – leukaemia proto-oncogene 2 protein 
Bcl-2 homolog domain -3 




bovine serum albumin 
 
buffered saline solution 
 
cellular adhesion molecules 














direct immuno-fluorescence antibody 
 











FCS   
FITC  
HBSS -  






IL   
LDH  




MCP-1   
MOI   
MOMP  
NAD   
enzyme immunoassays 
endothelial growth medium 
Glu-Leu-Arg 
eagle’s minimum essential medium 
 
enzyme- linked immunosorbent assay 
 
foetal bovine serum 
fetal calf serum 
flourescein isothiocynate 
hanks’ balanced salt solution 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
horseradish peroxidase 
human intestinal microvascular endothelial cell 
human umbilical vein endothelial cell 
intercellular cell adhesion molecule 
 









monocyte chemotactic protein-1 
 
multiplicity of infection 
major outer membrane protein 








PID   
PMEC   
PS  
Puma 

















Open Reading Frame 
platelet activating factor 
poly (DAP-ribose) polymerase 
peripheral blood mononuclear cells 
phosphate buffered saline (pH 7.4) 
pelvic inflammatory disease 
 
polyp microvascular endothelial cell 
phosphatidylserine 
p53 upregulated modulator of apoptosis 
recombinant long R insulin –like growth factor-1  
reticulate body 
 
 recombinant terminal deoxynucleotidyl transferase 
 
recombinant human endothelial cell growth factor 
recombinant human fibroblast growth factor-B 
ribonucleic acid 
Roswell Park Memorial Institute 
soluble intercellular adhesion molecule 






tumor necrosis factor alpha 
 
Terminal deoxynucleotidyl transferase dUTP nick end 
 x 
 
UV   
VAD-FMK  
VCAM   
VEGF  






vascular cell adhesion molecule 
vascular endothelial growth factor 









































LIST OF FIGURES 
 
Figure Content Page 
1 Summary of Chlamydia trachomatis lifecycle 8 
2 Overview of the IL-8 dimer structure 15 
3 Structure of MCP-1monomer 17 
4 The structure of the ICAM-1 dimer  18 
5 Endothelial cells 19 
6 A summary of the steps that occur during transendothelial 
migration  22 
7 Demonstration of the layers obtained before and after 
centrifugation during isolation of monocytes and neutrophils 48 
8 Micrographs of uninfected HUVEC (A), LGV C. trachomatis 
serovar L2 (B) and Ocular Genital serovar E(C) 58 
9 Mean levels of IL-8 induced by different C. trachomatis serovars 
and controls after 24 hr of incubation, expressed per 100 cells 59 
10 Mean levels of MCP-1 induced by different C. trachomatis 
serovars and controls after 24 hr of incubation, expressed per 
100 cells 60 
11 Mean levels of ICAM-1 expression in C. trachomatis serovars 
infected HUVEC and controls 61 
12 A confluent monolayer of HUVEC grown in transwells for 
transedothelial migration assays. Cells were stained using the 
silver nitrate stain   63 
13 Mean number of migrated monocytes and neutrophils through 
HUVEC infected with different C. trachomatis serovars and 
controls after 24 hrs of incubation 63 
14 
 
Mean levels of  % cytotoxicty of HUVEC infected with different 
C. trachomatis serovars and controls after 24 hrs of incubation 64 
15 HUVEC monolayers TUNEL assay controls. 66 
16 Micrographs of TUNEL stained HUVEC infected with 
Chlamydial serovar L1 (A and B) and L2 (C and D) 67 
17 Micrograph of TUNEL stained HUVEC infected with 
Chlamydial serovar L3 (A and B) and E (C and D), 24 hours post 68 
 xii 
exposure 
18 Micrographs of Caspase stained HUVEC 70 
19 Standard Curves for IL-8 triplicate experiments 108 
































LIST OF TABLES 
 





Temporal change in the aetiology of genital ulcers in Durban, 
South Africa 
Aetiology of male urethritis in Durban 






4 IL-8 Production by HUVEC, optical density (pg/ml), calculated 
concentration and concentration per 100 ml 
106 
5 MCP-1 Production by HUVEC, optical density (pg/ml), 
calculated concentration and concentration per 100 ml 
107 
6 Optical density of ICAM-1 produced by HUVEC infected with 
C. trachomatis serovars and controls, measured at 450 nm 
110 
7 Raw data absorbance readings measured at 450  nm for the LDH 
cytotoxicity assay of HUVEC infected with different C. 




8 Values after subtraction Culture Medium control background 
control average absorbance values from experimental wells 
112 
9 Calculated % Cytotoxicity of different chlamydia serovars 112 
10 Number of cells migrated during the transendothelial migration 
assay 
113 













LIST OF STATISTICAL ANALYSIS 
 
Page Statistics 
114 Interleukin-8  
116 Monocyte Chemotatctic Protein-1  
118 Intercellular Cell Adhesion Molecule-1  
121 Transendothelial migration of neutrophils 
122 Transendothelial migration of monocytes 


























This study was approved by the Biomedical Ethics Committee of the University of 




All Chlamydia trachomatis serovars (L1, L2, L3 and E) successfully infected and 
replicated in HUVEC after 24 hours of infection. Only L3 stimulated significantly 
higher production of IL-8, MCP-1 and ICAM-1 by HUVEC as compared to the 
ABSTRACT 
 
Although both are caused by Chlamydia trachomatis, Lymphogranuloma Venereum 
(LGV) presents differently from the infections caused by Oculogenital (OG) strains. 
The endothelium of blood and lymph vessels allows passage of cells to the site of 
infection. Endothelial cells also secrete chemokines and cell adhesion molecules 
which act as attractants and binding sites for various cellular immune components. 
Since LGV biovar affect the lymphoid tissue we studied the effect of C. trachomatis 
on endothelial cells. 
 
Human umbilical vein endothelial cells (HUVEC) were infected with C. trachomatis 
LGV serovars L1, L2, L3 and the OG strain E at multiplicity of infection (MOI) of 1 
and incubated for 24 hours. Stimulation of Interleukin-8 (IL-8) and monocyte 
chemokine protein-1 (MCP-1) chemokines and the intercellular adhesion molecule -1 
(ICAM-1) were quantified by enzyme linked immunosorbent assays (ELISA). 
Transendothelial migration of neutrophils and monocytes was carried out in 
transwells.  The lactate dehydrogenase (LDH) release assay was used to measure cell 
necrosis. Apoptotic cell death was analysed using the BioVisionTM CaspGLOW 
Fluorescein Caspase Staining Kit and DeadEndTM Colorimetric Terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) system with the C. 
trachomatis Culture Confirmation kit as a counter stain. 
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negative control and mock-infected cells. However, the remaining LGV serovars (L1 
and L2) and the OG serovar E showed no significant difference in the stimulation of 
IL-8, MCP-1 and ICAM-1 when compared to the controls. Comparison of LGV and 
OG serovars showed no significant difference between these two biovars in inducing 
production of IL-8 and MCP-1, but L3 stimulated ICAM-1 at a significantly higher 
level than E. There was no significant difference in the number of migrated 
neutrophils between untreated HUVEC, mock infected HUVEC and HUVEC infected 
with Chlamydia serovars. L2 and L3 had significally higher amount of migrated 
monocytes than the controls with L3 being the highest. L3 was the only serovar that 
had a significant level of cell death by necrosis. Apototic cells were observed in both 
uninfected and infected HUVEC which is due to normal cell turn over. None of the 
infected cells showed TUNEL positive nuclei. 
 
It can be concluded that L3 is more virulent than the other serovars during the first 24 
hours of infection. Infection with C. trachomatis serovars does not seem to cause any 
cell death by apoptosis 24 hours post infection. The only cell death that occurs is by 










Chlamydia species has been shown to induce the production pro-inflammatory 
molecules (chemokines and adhesion molecules) on the infected host cell. These in 
turn play a role in recruiting leukocytes to the site of infection (Stephens, 2003). 
Interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) chemokines recruit 
neutrophils and monocytes respectively to the site of infection, which are the main 
cells involved in the initial phase of fighting infections. There has not been much 
work done in comparing the different serovars in terms of stimulation of chemokine 
CHAPTER 1: INTRODUCTION 
 
Lymphogranuloma Venereum (LGV) serovars have been shown to be more virulent 
than the Oculogenital (OG) strains (Mabey and Peeling, 2002). Not much is known 
about differences in pathogenesis of LGV and oculogenital disease. 
Lymphogranuloma venereum serovars pass through the epithelial lining and seem to 
primarily infect macrophages that migrate to the regional lymph nodes causing 
disseminated infection. The OG biovars however infect the mucosal epithelial surface 
of the eye and genital tract and are mainly confined to that position (Mabey and 
Peeling, 2002). This study focuses on endothelial cells since they line the lumina of 
lymphatic vessels which are used for migration into the lymphnodes. The endothelium 
plays a crucial role in immunity in that recruited immune cells have to pass through it 
in a process known as extravasation to get to the point of infection; they also secrete 
mediators such as chemokines and cell adhesion molecules which act as attractants 




production by the infected cell. Most of the studies focus on Chlamydia pneumoniae 
without comparison between strains or biovars. 
 
Furthermore, there has been some contradicting reports regarding Chlamydia 
trachomatis and apoptosis with some research showing that Chlamydia is anti-
apoptotic and others that Chlamydia infection does induce apoptosis. Fan et al. 
(1998), Dean and Powers (2001), Fischer et al. (2004), Dong et al. (2005) and Ying et 
al. (2005) have done studies which support the anti- apoptotic characteristics of C. 
trachomatis. In contrast, studies done by Ojcius et al. (1998), Jean-Luc et al. (1999) 
and Samuel and Stephens (2001), stipulate that C. trachomatis does induce apoptosis. 
Cytotoxicity of C. trachomatis infected cells has been shown to be caused by a 
protein coded for by the clostridial toxin B gene present in the Chlamydia genome and 
LGV-2 serovar seems not to posses this gene (Belland et al., 2001). However not 
much is known about the rest of the serovars. More work needs to be done on 
comparing the OG strains with LGV strains, in terms of how they kill cells i.e. type of 
cell death and whether there is a difference in cytotoxicity levels amongst the strains 
on endothelial cells. This study aims to identify whether there is any cytotoxic effect 
and/or cell death in endothelial cells infected with C. trachomatis and if there is, 
which mechanism of cell death occurs and whether there are differences in that 
respect between LGV and OG strains. 
 
This comparison includes: 
i. Production of chemokines; IL-8 and MCP-1 and insoluble intercellular cell 
adhesion mol-1(ICAM-1) by endothelial cells infected with the two biovars. 
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ii. Promotion of transendothelial migration of neutrophils and monocytes by the 
two biovars.  
iii. Differences in endothelial cell death and mechanism of death i.e. by apoptosis 
or necrosis. 






















CHAPTER 2: LITERATURE REVIEW 
 




C. trachomatis belongs to the genus Chlamydia which originally had 2 species, C. 
psittaci being the second species. Later a third species C. pneumoniae was discovered 
by Gryston et al. in 1989 which was later, together with C. psittaci classified in a 
different genus, Chlamydophila. Currently the family Chlamydiaceae consists of two 
genera, Chlamydia and Chlamydophila and belongs to the order Chlamydiales, which 
falls under the phylum Chlamydiae (Everett et al., 1999). 
 
2.1.2 Characteristics and Morphology 
 
C. trachomatis has an outer membrane which resembles that of Gram negative 
bacteria hence Chlamydia are classified as gram negative bacteria. Different from 
most bacteria, Chlamydia do not have N-acetyl muramic acid in their cell wall. They 
are aerobic obligate intracellular parasites (Fukuda et al., 2005). These bacteria 
depend entirely on their eukaryotic host cells to synthesize ATP; hence they cannot 
survive outside the host cell and can only be propagated in tissue culture systems. 
Their ribosomes are of prokaryotic origin and they have both DNA and RNA in their 




2.1.3 Life-Cycle of Chlamydia trachomatis  
 
Chlamydia trachomatis has been shown to have a biphasic lifestyle. It infects the host 
cell as an elementary body which is 0.3µm in diameter. The elementary body (EB) is 
metabolically inactive and resembles a spore. Infection occurs through parasite 
specific endocytosis after adhesion of C. trachomatis to the target cell. The C. 
trachomatis cell remains engulfed in the phagosome preventing phagolysosomal 
fusion. Whilst in the host cell, the elementary body transforms after 8-10 hours into a 
metabolically active form called the reticulate body (RB). This process of 
transformation from EB to RB has been shown to be characterized by 2 biochemical 
events. Firstly there is synthesis of chlamydial protein followed by the reduction of 
the Major Outer Membrane Protein (MOMP) with loosening of its cross-linked 
disulfide bonds (Moulder, 1991). However more investigations still need to be done to 
elucidate what really happens during this stage.  
 
The reticulate body starts to divide by binary fission and replicates every 2-3 hours 
within an inclusion body. This inclusion body is equivalent with the original phago-
endosome. On Giemsa stain, the inclusion bodies are vacuolar and granular in 
appearance. They are single and refract light when viewed under a bright-field 
microscope. The replication of the RBs within the inclusion body goes on for about 
20 hours. Mature RBs then condense and the disulfide bridges of the MOMPs develop 
allowing the mature RBs to redifferentiate into elementary bodies. One phagosome 
has been shown to produce about 100-1000 elementary bodies. These elementary 




Chlamydia trachomatis is classified in to two human biological variants according to 
the characteristics of the disease caused by each group .i.e. Lymphogranuloma 
Venereum (LGV) and Oculogenital (OG) biovars (Gomes et al., 2004).In the 1960s 
the biovars were further divided into serotypes/serovars by measuring the level of 
toxicity of C. trachomatis strains on mice after exposure to antibodies. This is known 
as the “mouse toxicity prevention test” (Barnes, 1989). Wang and Grayston (1974) in 
further elucidated the serovars serologically by using a microimmunoflouresce test 
using monoclonal antibodies (MAb) against MOMP. Although Gomes et al. (2004) 
 Summary of Chlamydia trachomatis lifecycle, from Microbiology and 
Immunology on-line by Gene Mayer.  
 
2.1.4 Biovars and serovars of Chlamydia trachomatis 
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argues that the phylogenetic data does not entirely offer a definite grouping of the 
serovars based on their tissue tropism and virulence characteristics, the grouping of 
serovars into biovars is generally accepted. The OG biovar is made up of serovars A-
C and Ba, which cause trachoma, and serovars D-K which cause urogenital infections. 
The LGV biovar consists of serovars L1, L2, L2a and L3 (Gomes et al., 2004). These 
serovars have been shown to be more invasive than the OG serovars. Animal models 
have also demonstrated the LGV biovar to be more virulent than OG biovar (Mabey 
and Peeling, 2002). Whereas the OG serovars infect the mucosal epithelial surface of 
the eye and genital tract and are mainly confined to that position, Mabey and Peeling 
(2002) state that, “LGV seems to primarily infect monocytes and macrophages and 
can pass through the epithelial layer infecting the regional lymph nodes and may be 
dispersed throughout the body causing disseminated infection”.  
 
2.1.5 Chlamydia infections 
 
2.1.5.1 Lymphogranuloma Venereum 
 
The pathogenesis and manifestation of LGV have shown to vary, but the most 
distinctive presentation is genital bubonic disease. The classic manifestation is as 
follows: after 3-30 days of incubation, a small painless lesion which can go unnoticed 
by the infected individual occurs at the site of infection. This is followed by 
inflammation of inguinal lymph nodes. Lymphadenopathy of rectum and the anus can 




Involvement of the inguinal lymph nodes is more common in men due to the 
lymphatic drainage pathway, as for women, their lymphatic drainage of the vagina 
and cervix is to the retroperitoneal lymphnodes i.e rectal and perianal. Hence women 
tend to suffer from proctitis. Homosexual men who are receptive during anal sex can 
also develop proctitis. Patients can also experience headaches, fever and painful 
muscles. If not treated, hindrance of the lymphatic drainage can lead to elephantiasis 
in the involved area. Ulcers, stricture and fistulae can occur in the rectal area. (Mabey 
and Peeling, 2002). 
 
2.1.5.2 Urogenital Infection 
Infection with C. trachomatis serovar D-K can cause both asymptomatic and 
symptomatic urogenital infection (Morre’ et al., 2000). The common manifestation of 
this infection in men is urethritis. This is characterized by burning and pain during 
urination, as well as discharge and inflammation of the urethra. If the anus was the 
point of contact, it can get inflamed, tender and painful; oro-genital contact can result 
in a sore throat, .i.e. pharyngitis. The main manifestation in women is cervicits. Lower 
abdominal pain can occur as a result of pelvic inflammatory disease (PID). PID can 




Trachoma is a chronic infection of the eye caused by continual infection of the 
conjuctiva and cornea by C.trachomtis serovar A-C. Consequently there is 
inflammation of the conjunctiva and follicle formation. This in turn leads to scarring 
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of the conjuctiva which ultimately result in turning in of eyelids. If the cornea also get 
affected it results in blindness (Barnes, 1989). 
 
2.1.6 Epidemiology of Chlamydia trachomatis infections 
 
The epidemiology of LGV is not clearly defined because it is clinically difficult to 
positively differentiate it from other STDs which cause genital ulcers with formation 
of a bubo such as chancroid. Diagnosis in the laboratory is more reliable if molecular 
techniques are applied (Sturm et al., 2005; Alexander et al., 2008). The disease is 
endemic in parts of Asia, Africa (including Southern Africa), the Caribbean and South 
America and it is rare in industrialized countries (Mabey and Peeling, 2002). LGV is 




Urogenital infections are also spread worldwide (Barnes, 1989) but, like for LGV not 
much is known about the epidemiology because of difficulties in differentiating 
between Chlamydia urethritis with other aetiology. C. trachomatis is the main cause 
of urethritis in developed countries while in developing parts of the world other 
causes play a major role as well (Table 2; (Sturm et al. 2004).  
 







The epidemiology of trachoma on the other hand can easily be established. Generally 
it is a common cause of blindness worldwide, World Health Organization (WHO) 
states that over 140 million people are infected, and it is estimated that more than 500 
million people are at risk of getting the disease. Trachoma is most prevalent in 
developing countries such as Asia and Africa, and also in Latin America. 
Approximately 6 million people are blind in the above mentioned geolocations due to 
trachoma and it is 2 to 3 times more common in women than in men. It is mostly seen 
in overcrowded and poverty stricken places. Poor hygiene seems to be a major factor 
facilitating the spread of the disease (WHO, 2010).  
 
2.1.7 Laboratory detection of Chlamydia trachomatis 
 
During the 1980s a major breakthrough was made with the development of tissue 
culture as a means of diagnosing infection with C. trachomatis. Culture detection 
methods are based in detection of viable organisms and these are detected as inclusion 
bodies by immunofluorescence (Chernesky, 2005). A number of commercial kits to 
detect chlamydial antigens have been developed. These include Enzyme 
Immunoassays (EIA) and Direct Immuno-Fluorescence Antibody (DFA) tests 
(Chernesky et al., 1986; Gift et al., 1999). Since tissue culture is too cumbersome for 
routine use and antigen detection tests lack sensitivity, nowadays these have been 
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replaced largely by molecular methods. These are also commercially available. 
However, these tests do not differentiate between biovars.  
 
Serology tests for the detection of antibodies have been used since the 1970s. The 
method of choice is the microimmunofluorescence test developed by Wang and 
Grayston in 1974. This test is technically demanding and lacks specificity. Antibody 
detection tests are only recommended for patients with tubal factor infertility, 
neonates, and occasionally when there are no bubo aspirates for LGV infections 
(Chernesky, 2005). 
 
2.1.8 Treatment of Chlamydia infections 
 
Uncomplicated Chlamydia infections which are at an early stage can be treated using 
antibiotics. The recommended antibiotics are azithromycin and doxycycline (CDC, 
2006). However other antibiotics from the macrolide or azolide group and 
tetracyclines can also be used. (Marrioti, 2004).  
 
Chemokines and Cell Adhesion Molecules (CAMs) are protein molecules which play 
a major role in immunological responses. Chemokines are protein molecules secreted 
by cells to recruit immune cells. Chemokines can be either be proinflammatory thus 
involved in recruiting cells to a site of infection or homeostatic in that they control 
circulation of immune cells in the body to maintain tissue balance and development. 
Chemokines acquire their name from their chemotaxis nature to neighbouring 
2.2 CHEMOKINES AND CELL ADHESION MOLECULES 
 
 14 
responsive cells, hence chemotactic cytokines or chemokines (Zhang et al., 1994; 
Fernandez and Lolis, 2002). These proteins share common structural characteristics 
such as their conserved primary structures. They are about 8-10 kilo Daltons in size 
and have four cysteines in a particular position. Chemokines are grouped into two 
subfamilies: the C-C proteins family and the C-X-C proteins family and this is based 
on their structure and genetics (Zhang et al., 1994).  
 
Chemokines and Cell Adhesion Molecules are proteins situated in the surface of the 
cell. Their functions involve binding to other cells as an immune response and to the 
extra cellular matrix. They have three domains, namely: intracellular, transmembrane 
and an extracellular domain. Cell adhesion molecules are grouped into four families, 
which are cadherins, selectins (these two are also classified as calcium dependent 
CAMs), intergrins and immunoglobulin superfamily (IgSF). The first two groups are 
calcium dependent CAMs while the latter two are classified as calcium independent 
CAMs (Brackenbury et al., 1981). 
 
2.2.1 Interleukin-8  
 
Interleukin-8(IL-8) is produced by numerous cell types such as macrophages, 
epithelial cells and endothelial cells. Utgaard et al. (1998) has shown that 
unstimulated microvascular endothelial cells such as human intestinal microvascular 
endothelial cells (HMIEC) and polyp microvascular endothelial cells (PMEC) contain 
lL-8 in intracellular vesicles known as a Weibel Palade bodies. However these IL-8 
containing granules are not present in unstimulated HUVEC. In this endothelial cell 
line IL-8 is only expressed on stimulation. 
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Based on its structural characteristics IL-8 belongs to the C-X-C subfamily of 
chemokines. This group unlike the C-C subfamily is known to have another amino 
acid between two cysteine residues situated near the N-terminus (Skelton et al., 
1999). IL-8 has the four cysteines typical of any chemokine structure. These cysteines 
are joined by intramolecular disulfides bonds, with the first cysteine joined to the third 
one and the second joined to the fourth cysteines. The first two cysteines as already 
mentioned are situated near the N-terminus, the third is found in the centre and the 
last one in the C-terminus of the molecule (Fernandez et al., 2002). 
 
Figure 2:
Interaction of the loops of the amino acids and cysteines form a tertiary structure with 
3β sheets anti-parallel to each other and an α- helix at the C-terminus. Dimerization 
of the C-X-C is normally through the N-terminal β-strand resulting in a six-stranded 
 Overview of the IL-8 dimer structure adapted from Skelton et al. (1999). 
Showing dimerization of the C-X-C through the N-terminal β-strand resulting in a 
six-stranded β-sheet forming compact nearly spherical dimers. Also indicated is the 




β-sheet (Lowman et al., 1996), which form compact nearly spherical dimers (Zhang 
et al., 1996; Skelton et al., 1999). C-X-C chemokines are further divided into 2 
categories, ELR positive and ELR negative. The ELR positive category which IL-8 
belongs to, have a Glu-Leu-Arg (in short ELR) amino acid sequence near the N-
terminus. The ELR and residues in the N loop have been shown to be important in 
binding of the chemokine to its receptors (Lowman et al., 1996). 
 
Interleukin-8 is involved in innate immunity. It acts as a chemoattractant. It primarily 
recruits neutrophils to the site of inflammation. This is why it is also referred to as 
neutrophil chemotactic factor. IL8 is produced by infected cells, for instance 
endothelial cells and released into the surrounding tissue. Neutrophils migrate in the 
direction of the chemokine producing cells. In this process IL8 binds to the IL8 
receptors receptors in the membrane of the neutrophil. This is followed by removal of 
the chemokine to maintain a concentration gradient in the direction of the producing 
cell layer. MCP-1 functions in a similar way, macrophages instead of neutrophils 
(Utgaard et al., 1998). 
 
2.2.2 Monocyte Chemotactic Protein-1 
 
Monocyte Chemotactic Protein-1(MCP-1) is produced by a number of cells following 
stimulation. These cells are endothelium, epithelium, smooth muscle cells, fibroblasts 
and mononuclear leukocytes. (Hasegawa et al., 1999). 
 
MCP-1 belongs to the C-C subfamily of chemokines, which unlike the C-X-C do not 
have an amino acid between the two cysteines near the N-terminus, hence no ‘X’ 
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between the ‘CC’. Like with all chemokines the dimerization of MCP-1 results into 3 
anti-parallel β-sheets (β1, β2, and β3) from the N-terminus to C-terminus, however 
unlike the C-X-C subfamily in which the dimer is found mainly between β1 of two 
subunits, the dimmers of C-C chemokines occur near the N-terminus along a β0 sheet. 
This results in long cylindrical dimers typical of MCP-1 (Figure 3, Zhang et al., 
1996). Mutagenesis studies by Zhang et al. (1996) have shown that the N terminus of 




:  Structure of MCP-1β monomer adapted from Zhang et al. (1996) showing 
three β-sheets (β1, β2, and β3) and the amino (N) and carboxy(C) termini. The 
angular cylinders indicate the disulfides bonds. 
 
Like all chemokines, it acts as a chemo attractant, recruiting monocytes to the site of 
infection where they mature into macrophages (Skelton et al., 1999) 
 
2.2.3 Intercellular Cell Adhesion Molecule-1 
Intercellular cell adhesion molecule-1 (ICAM-1) is produced by activated endothelial 
cells. The human gene which encodes for ICAM-1 is located in chromosome 19 and 
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its expression can be induced by a range of mediators including infectious agents 
(Rahman and Fazal, 2009) 
 
Intercellular cell adhesion molecule-1 is a cell surface glycoprotein with a molecular 
weight ranging from 76 to 114 kDa and consists of 505 amino acids. This 
glycoprotein belongs to the immunoglobulin super family. It has 5 extracellular Ig-
like domains (D1-D5), a hydrophobic transmembrane domain, and a short 
cytoplasmic domain of 28 amino acids (Staunton et al.,1988; Springer, 1990;). The 
D1 domain acts as a binding site for Leukocyte Function-associated Antigen (LFA-1) 
whereas D3 acts as the binding site for Macrophage-1 antigen (Mac-1). (Fig. 4) (Bella 
et al., 1998). 
 
Figure 4: The structure of the ICAM-1 dimer adapted from Bella et al. (1998) 
showing the crystallographic dimer with D1 and D2 domains and antiparallel ß-sheets 
between the G strands. 
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Binding of ICAM-1 to ß-intergrins allows adhesion of the recruited neutrophils, 
monocytes and lymphocytes to the endothelium resulting in transendothelial 
migration also known as diapedesis. The first role involves the extracellular domain 
which has been shown to facilitate firm adhesion of leukocytes to the endothelium 
(Lyck et al., 2003; Engelhardt and Wolburg, 2004). The second role involves the 
cytoplasmic domain which has been indicated by mutagenesis studies to play an 
important role in promoting transendothelial migration of leukocytes (Greenwood et 
al., 2003; Lyck et al., 2003). 
 
2.3 ENDOTHELIAL CELLS 
 
Endothelial cells line the lumina of blood and lymphatic vessels, forming the 
endothelium (Nisato et al., 2004). The cells are flat with a diameter of 10-20 µm and 
approximately 1-2 µm thick giving the endothelium a pavement –like appearance 
(Fig. 5). 
 
Figure 5:  showing endothelial cells with the blue nucleus and the silver nitrate stained 
black intercellular junctions. Original magnification 400X. (From: School of Anatomy 
and Human Biology, University of Western Australia). 
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Endothelial cells are involved in a range of vital physiological processes. They have 
been shown to secrete mediators which may induce biological reactions by an 
assortment of signal-transduction mechanisms. These mediators such as chemokines 
and cell adhesion molecules act as attractants and binding sites for various cellular 
immune components facilitating diapedesis. Endothelial cells also act as 
discriminatory filters by controlling the passing of soluble molecules. They are also 
involved in angiogenesis, which is the formation of new blood vessels (Farjado, 
1989). 
 
2.4 EXTRAVASATION/ TRANSENDOTHELIAL MIGRATION 
 
Infection or injury to the body results in a cascade of events known as the 
inflammatory response. This response provides a mechanism to rid the host of 
infection and to repair the damage (Fig. 6). A major component of the inflammatory 
reaction is for the leukocytes to migrate from the blood through the endothelium to 
the infected tissue, a process known as extravasation. This transendothelial migration 
(TEM) of leukocytes is a complex, well regulated multistep process which involves a 
number of signaling molecules. The first step in TEM encompasses rolling. In the 
absence of any injury or infection the endothelial layer and the intra-vascular 
leukocytes are in a resting state in which there is no interaction. Upon stimulation the 
endothelial cell start secreting chemokines which recruit the leukocytes and the 
expression of selection ligands, which in turn capture the leukocytes from the 
bloodstream by “tethering”. The chemokines are leukocyte receptor specific (Krüll et 
al., 1999; Wang. and Grayston, 2002; Rahman and Fazal, 2009). 
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Some chemokines are broad acting whereas others are leukocyte type specific. For 
instance, Platelet Activating Factor (PAF) has been shown to stimulate numerous 
types of   leukocytes (Zimmerman, 1992; Simon et al., 1994)   whereas IL-8 and 
MCP-1 are specific for recruiting neutrophils and macrophages respectively (Utgaard 
et al., 1998). Broad acting transmembrane protein P-selectin has been shown to be the 
most rapid selectin in recruiting neutrophils and is able to maintain the initial rolling 
of neutrophils. Rolling is temporary and is stopped when firm adhesion occurs 
through the binding of the integrin which necessitates Gα1-linked receptors. PAF and 
IL-8 have been shown to activate this Gα1 pathway. Utgaard et al. (1998) further 
argues that IL-8 has the advantage over PAF by being able to support the subsequent 
firm binding of neutrophils by Gα1 receptors, and its rapid release. It is restricted to 
neutrophils hence more specific. Even though not much work has been done in this 
regard for MCP-1 as compared to the IL-8 chemokine, MCP-1 is also leukocyte-type 
specific and hence it is safe to say that it posses the same advantages that IL-8 has 
compared to broad acting chemoattractants. 
 
The 2nd step is the firm adhesion, arrest or tight binding of leukocytes to the 
endothelium. In this stage there is up-regulation of expression of ICAM-1 receptors 
on the activated endothelial cell surface. Molecules that bind to the endothelial 
receptors are activated on the leukocytes like β2 integrins, LFA-1, α1β2, CD11a 
(CD18) and Mac-1(αMβ2, CD 11b/ CD18). The ICAM-1 interacts with receptors on 
the leukocytes facilitating the arrest or tight adhesion. This in turn makes it possible 
for the leukocytes to pass across the endothelium through a process known as 
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diapedesis which is followed by migration to the affected tissue (Krüll et al., 1999; 
Rahman and Fazal, 2009). 
 
Figure 6: A summary of the steps that occur during transendothelial migration, 
adapted from Garland Science 2005. 
 
There has been many debates on which route is taken by the leukocytes during this 
transmigration, is it transcellular or paracellular? In ex-vivo experiments, the path the 
leukocytes take seem to be dependent on the type of stimuli, activation state, origin of 
endothelial cells (HUVEC, HMIEC, PMEC) and type of leukocytes, however further 
studies still need to be done to elucidate and validate the determinants for each route 







Several studies have been done on interaction of Chlamydia spp with host cells. Krüll 
et al. (2004) reported that C. trachomatis serovar K was able to infect HUVEC. After 
an exposure period of 24 hours, the bacteria did infect the cells, but this did not 
stimulate any production of IL-8 or cell surface ICAM-1. These molecules were 
however induced when HUVEC was infected with C. pneumoniae strain TW 183. 
The authors also referred to their preliminary results on C. trachomatis serovar L2 and 
E stating that even though both these serovars successfully infected HUVEC, there 
was no production of IL-8 and MCP-1. Therefore, C. pneumoniae was able to induce 
2.5 INTERACTION OF CHLAMYDIA WITH ENDOTHELIAL CELLS 
 
2.5.1 Production of Chemokines and Adhesion molecules 
 
Chlamydia spp has been shown to induce the production of chemokines and 
expression of adhesion molecules on the infected host cell. These in turn play a role in 
recruiting leukocytes to the site of infection. This is part of the inflammatory response 
which is the hallmark of Chlamydia infection. Chlamydia is one of the pathogens 
which cause destructive delayed chronic inflammatory response (Stephens, 2003). 
Chlamydia infects non immune cells and elicits the production of proinflammatory 
molecules such as IL-6, IL-1α, IL-11, IL-8 and MCP-1. This results in an acute 
inflammatory response followed by a chronic phase which is characterized by the 
build up of a mononuclear infiltrate including macrophages and lymphocytes. These 
inflammatory responses consequently lead to cell proliferation and damage to the 
tissue (Stephens, 2003; Ward, 1999).  
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early and rapid signal transduction but the different serovars of C. trachomatis did 
not. 
 
Fukuda et al. (2005) showed that both C. trachomatis LGV-2 and E did induce 
production of IL-8 but by peripheral blood mononuclear cells (PBMC) and epithelial 
cells. This raises the question whether this feature is unique for epithelial cells and 
PBMCs only. Similar results were reported by Molestina et al. in 1998 who reported 
that C. pneumoniae induced the expression of not only IL-8, but MCP-1 and sICAM-
1 by HUVEC after 24 hours. Fukuda’s data confirm observations on the expression of 
cell bound E-selectin, ICAM-1 and VCAM-1 by C. pneumoniae infected HUVEC 
made formerly by Krüll et al. (1999). 
 
2.5.2 Transendothelial migration of neutrophils and monocytes 
 
As already mentioned chemokine and cell adhesion expression leads to recruitment of 
immune cells to the site of infection which in turn result in transendothelial migration. 
Few studies have been done on transendothelial migration of leukocytes during 
Chlamydial infection. A study done by Molestina and colleagues in 1999 even though 
the main focus was on C. pneumoniae also looked at C. trachomatis infection. The 
authors reported that C. trachomatis L2 demonstrated a minor raise in neutrophil 
transendothelial migration and a significant transendothelial migration of monocytes 
compared to mock-infected cells. This was regardless of lack of IL-8 induction or 
MCP-1 induction. They attributed this to the possibility that a different chemotactic 
factor was responsible for this monocyte migration.  
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The oculogenital serovars A and E failed to induce MCP-1 and IL-8 stimulation in 
HUVEC. C. pneumoniae however promoted up regulation of IL-8 and MCP-1 and 
also promoted transendothelial migration of both neutrophils and monocytes. They 
then concluded that up regulation of MCP-1 and IL-8 by endothelial cells was unique 
to C. pneumoniae. However, C. trachomatis up regulated IL-8 and MCP-1 in 
monocytes and epithelial cells. Hence the authors concluded that stimulation of 
chemokine production is cell type specific.   
 




Pathogen induced cell death was first described by Hirano and Ruebner in 1966. As 
time went on it was recognized that this occurs in a regulated and controlled manner 
and plays a major role in the pathogenesis of disease. In order to survive inside the 
host some micro organisms may kill the cell responsible for immunity as a form of 
defence. Some micro organisms especially those that live intracellularly, don’t 
instantly kill the host cell because they need it for replication and growth. However 
lysis will occur when the multiplied organism is ready to infect other host cells. Cell 









Apoptosis is a Greek word which means “falling”. Kerr et al. (1972) first described 
apoptosis based on morphological changes. Those included cytoplasmic and nucleus 
condensation, followed by disintegration of the cell into membrane-bound fragments 
known as apoptotic bodies. The plasma membrane remains intact. Apoptosis does not 
cause an inflammatory response because the apoptotic bodies are taken up by 
neighbouring cells in phagosomes. Apoptosis is a controlled mechanism of cell 
deletion, hence termed “programmed cell death”. It is used to remove dysfunctional 
cells. 
 
A study done on abnormal cell mutants by Hedgecock and colleagues in 1983 
revealed that there were gene products concerned with cell death during the 
development of an embryo. These products belonged to a family of proteases known 
as caspases. However, not all caspases are involved in apoptosis. The caspases 
involved in apoptosis include caspase 2, 3, 6, 7, 8, 9 and 10 (Creagh et al., 2003). 
These caspases are further grouped into two subgroups on the basis of their role in 
activating cell death and their structure. The first group comprises of initiator 
caspases, which are 2, 8, 9, and 10. As the name implies they are involved in initiating 
the apoptotic cascade by mediating dimerization which is needed for the caspase 
activation. The second group consists of caspase 3, 6 and 7 which are involved in 
cleaving and disassembling of the cell. They are activated through proteolysis 
(Boatright and Salvesen, 2003). 
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Some pathogens have been shown to be able to activate the caspase cascade hence 
inducing cell death. For instance C.trachomatis has been shown to manufacture a 
protein known as Chlamydia protein which activates apoptotic caspases by interacting 
with the Tumor Necrosis Factor family receptor death domains (Stenner-Liewen et 
al., 2002).  
 
It follows from the above that apoptosis cannot only be studied based on 
morphological changes but also based on the biochemical pathways involved. 
Therefore apoptosis is defined as caspase-mediated cell death which leads to the 
already mentioned morphological changes and elimination of the resulting apoptotic 




 The term necrosis is used to define any death of cells which is not apoptotic. Necrotic 
cell death differs from apoptosis in that it does not activate any intra-cellular 
biochemical process that leads to death of the cell (Levin, 1998; Levin et al., 1999). 
Necrotic cell death is accompanied by cell lysis. Apoptotic cells which are not 
eliminated by phagocytosis can disintegrate and proceed to a stage known as 
apoptotic necrosis. Majno and Joris (1995) argues that it is possible for cells close to 
apoptotic ones to undergo necrosis even though apoptosis is regarded as a process 







Even though apoptosis and necrosis are the major mechanisms of cell death, more 
types of cell death have been proposed. One of them is oncosis. This term is used to 
describe the prelethal process which is characterised by organelle and cellular 
swelling. The membrane permeability also increases and breaks down. Even though 
the nucleus swells it does not fragment. Oncosis results in ATP depletion due to 
processes which cause consumption of energy in an uncontrollable manner. Some of 
this energy depletion has been shown to be caused by biochemical reactions catalysed 
by enzymes. For instance in an attempt to repair massive DNA damage, poly 2.4-di-
amino-6-pyrimidine (DAP)-ribose polymerase (PARP) increases its intake of its 
substrate nicotinamide adenine dinucleotide (NAD) which it uses to repair DNA, This 
means NAD has to be resynthesised which can result in depletion of ATP and 
subsequent death of the cell due to lack of energy (Walisser et al., 1999). Induction of 
oncosis by pathogens has been demonstrated on MA 104 cells infected with Rotavirus 





Another proposed type of cell death is autophagy. This refers to the degradation of 
cellular debris within the dying cell in vacuoles called autophagic vacuoles. This is 
also known as Type II cell death. The morphological changes involved are 
vacuolisation, cytoplasmic contents degradation and minor condensation of the 
chromatin. Autophagic cells can also be phagocysed. Autophagy does not cause any 
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inflammatory reaction since the components are degraded in autophagic vacuoles. 




The last type of cell death is pyroptosis. This form of death involves Caspase 1 
activity and results in the breakdown of the cytoplasmic membrane. Hence it leads to 
a proinflammatory reaction. Caspase-1 activates the inflammatory cytokines IL-1β 
and IL-18 proforms. There are some pathogens which have been shown to cause cell 
death by the pyroptosis pathway. Some studies have shown that salmonella and 
shigella cause pyroptosis in macrophages (Zychlinsky et al., 1994; Hersh et al., 1999; 
Obregon et al., 2003). 
 
Fink and Cookson (2005) suggest that that there are other types of cell death that there 
are still undiscovered or uncharacterised. They further elaborate that death of a cell 
may involve numerous pathways at the same time and communication between the 
pathways can allow a controlled form of death. They postulate that no distinct cell 
death programme is responsible for the death of a cell, but that there is an overlap of 
several cell death types. This is further supported by former studies by Ankarcrona et 
al. (1995) and Kostin et al. (2003). 
 
2.6.7 Measurement of Cell death 
 
Although the understanding of mechanisms of cell death is improving, methods to 
study this are complicated. Fink and Cookson. (2005) argue that most of the methods 
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to establish and quantitate apoptosis are inadequate to prove that no other cell death 
pathways occur at the same time. For instance different stains and fluorescent dyes are 
used to identify condensed chromatin but oncotic cells also show condensed 
chromatin. Visualising of DNA fragmentation by gel electrophoresis is also used 
since it was formerly described as a trademark of apoptosis. However, necrotic cells 
also have been shown to have nuclear fragmentation (Collins et al., 1992) and 
TUNEL positive nuclei (Grasl-Kraupp et al., 1995; de Torres et al., 1997). 
Measurement of lactate dehydrogenase is used to identify necrosis since as the cell 
looses its integrity it releases cytoplasmic enzymes. Even though it shows that the cell 
membrane is destroyed it doesn’t provide information on which pathway led to that. 
The annexin V test which measures phosphatidylserine (PS), has been shown not to 
be able to discriminate between oncotic, necrotic and apoptotic cells (Lecoeur et al., 
2001). 
 
Caspase activity measurement is considered to be more specific than the other 
methods. This test is based on conjugation and proteolysis of tetrapeptide substrates 
with caspase cleavage sites. The products formed are detected by means of 
fluorometric or colorimetric assays. The problem with this test is that it measures the 
enzyme activity in a population of cells and not in a single cell. Conjugating caspase 
inhibitors with peptide markers which mimic the caspase cleavage sites can lead to 
non-specific binding due to overlapping of caspase activity (Thornberry et al., 1997; 
Villa et al., 1997). 
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With all these test limitations, cell death measurements are limited to measuring cell 
membrane integrity and the classic markers of apopotosis. So far, there are no 
established techniques to identify other types of cell death.  
 
2.6.8 Chlamydia induced Cell death 
 
Since Chlamydia trachomatis is an obligate intracellular organism, it needs its host 
cell for survival. Hence, it has developed strategies to keep the host cell viable 
following infection. However the pathogen needs to exit the infected cell, and escape 
the immune response of the host cell. This can be achieved by inducing apoptosis 
during which cell contents, including the intracellular pathogen, is packed in 
membrane bound compartments. There are contradicting reports with some research 
saying Chlamydia is anti-apoptotic and others saying Chlamydia infection does 
induce apoptosis. 
 
Samuel and Stephens (2001) showed that there was phosphatidylserine (PS) 
externalisation on the surface of human endothelial, epithelial, monocytic and 
granulocytic cells infected with C. trachomatis (L2) and C. pneumoniae. PS 
externalisation is an indication that the cell is at an early stage of apoptosis. The PS 
externalisation was immediate and was not affected by a broad spectrum of caspase 
inhibitors. The authors argue that maybe the caspase cascade is either not needed or 
bypassed. They therefore concluded that the involvement of caspases to the chlamydia 
induced apoptotic process is minor. This is consistent with the findings of Ojcius et al. 
(1998). C. pneumoniae has also been shown to induce apoptosis in a caspase 
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independent manner in coronary artery endothelial cells (Schoier et al., 2005). It was 
also transient .i.e. withdrawal of the stimulus resulted in loss of PS externalisation.  
 
Ojcius did further research in 1999 with Jean-Luc as the first author. They reported 
that C. trachomatis infection of HeLa cells leads to apoptosis. They then proceeded to 
do in vitro studies in mice and they found that the infected mice had a significant 
amount of apoptotic cells in the uterus and oviducts after 2 to 7 days of infection. 
However even though they observed apoptotic cells in the endocervix the number was 
not significant and they argued that it might be due to shedding of the dead cells 
because large clumps of infected cells were observed there. Their observations were 
supported by Gibellini et al. (1998). They reported that apoptosis was evident on 
LLC-MK2 cells infected with C. trachomatis LGV-2 serotype or with C. psittasi.   
 
C. trachomatis has also been shown to have anti-apoptotic properties. There are 
several mechanisms involved in this anti-apoptotic activity. These include, cleavage 
of polyADP ribose and inhibition of the activation of caspase 3 in cells infected with 
Chlamydia (Fan et al., 1998). Blockage of mitochondrial cytochrome C release has 
also been demonstrated in chlamydia infected cells. It has also been shown that 
Chlamydia infection of cells leads to degradation of BH3-only proteins, which are 
bcl-2-interacting killer (Bik) protein, p53 upregulated modulator of apoptosis (Puma) 
and bisindolylmaleimide (Bim). These proteins belong to the B-cell lymphocytic-
leukaemia proto-oncogene-2 (bcl-2) family and are required for activation of the 
cytochrome c release mechanism. Their degradation results in loss of pro-apoptotic 
activity and hence the infected cell is protected against apoptosis (Fischer et al., 2004; 
Dong et al., 2005; Ying et al., 2005). Dean et al., 2001 also showed that Hela 229 
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cells infected with C. trachomatis resisted apoptotic stimuli in acute and persistent 
infections. The infected cells were stimulated with etoposide and staurosporine. They 
observed no DNA ladder and the cytochrome c remained intact in the mitochondria 
whereas the reverse was true for uninfected cells.  
 
Cytotoxicity by C. trachomatis has been described as early as 1944 when Rake and 
Jones described this in macrophages. In 2001, Belland and colleagues further 
classified the toxins involved and identified a clostridial toxin B gene encoded in the 
Chlamydia genome as the one responsible for cytotoxicity. This study was done on 
epithelial cells. They used strains, D, L2 and MoPn. MoPn was found to be more 
toxic than serovar D, whereas L2 did not show any cytotoxic effect. This 
corresponded with the absence in L2 of open reading frames (ORFs) (TC0437-0439) 
which are responsible for cytotoxity. They reason that lack of cytotoxicy of L2 on 
























CHAPTER 3: MATERIALS AND METHODS 
 
3.1. CELL CULTURES AND PROPAGATION OF ISOLATES  
Chlamydia trachomatis serovars L1 (ATCC® VR-901B), L2 (ATCC® VR-902B), L3 
(ATCC® VR-903) (Lymphogranuloma strains) and E (Ocular Genital strain) were 
used in this study. The LGV strains were kindly donated by Frans Radebe of the 
National Institute of Communicable Diseases and the serovar E was isolated by 
Maleka and colleagues (1996) from a male patient presenting with urethritis at the 
Prince Cyril Zulu Communicable Diseases Clinic in Durban. Typing of this strain was 
done using the monoclonal antibody microimmunofluoresence test by Dr Lampe at 
the Department of Medicine in the University of Washington, Seattle. The strains 
were kept as frozen stocks in the department of Medical Microbiology. McCoy cells 
were used for propagation of isolates and Human Umbilical Vein Endothelial cells 
(HUVEC) were used for experimental purposes. McCoy cells (American Type 
Culture Collection, number CRL-1696) were from frozen stocks whereas pooled 
cryopreserved HUVEC, in EGMTM -2 from Clonetics®. 
 
3.1.1 McCoy Cells 
3.1.1.1. Reconstitution  
 
A vial containing McCoy cells was removed from the -70ºC freezer and allowed to 
thaw. The vial was wiped with 70% ethanol and placed in a class II biological safety 
cabinet. The contents of the flask were diluted 1:10 in growth medium. This was done 
by adding 20ml of Eagle’s minimum essential medium (EMEM) manufactured by 
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Bio-WhittakerTM, Walkersville, MD,USA with L-glutamine (2mM) (Bio-
WhittakerTM, Walkersville USA) to a 75cm2 tissue culture flask. The EMEM was then 
supplemented with 2ml of heat inactivated foetal bovine serum (FBS). McCoy cells 
from the vial were then added to the flask. The flask was placed at 37ºC in a CO2   
incubator with 5% CO2 in air. After 24 hours, the cells were checked for confluency 
by observing them under an inverted microscope at 200X magnification. If 
confluency was observed, the cells were trypsinised (3.1.1.2) and if not the medium 





When 90-100 % confluency was reached, the medium was removed and the cell 
monolayer washed thrice with phosphate buffered saline (PBS, pH 7.4, Oxoid) 
without calcium and magnesium. The PBS was decanted and replaced with 1 ml of 
warmed trypsin-EDTA solution (0.05 % trypsin - 0.02 % versene BioWhittakerTM ). 
The flask was swirled gently in order to spread the solution evenly over the cell 
monolayer. Excess trypsin-EDTA solution was decanted leaving a small amount to 
cover the surface of the flask. The flask was incubated at 37 ºC for 30-60 seconds and 
tapped on the palm of the hand to facilitate easy detachment. Immediately after 
detachment, cells were resuspended in 1 ml of FBS to stop the action of the trypsin. 
The cell suspension was transferred to a 100 ml bottle containing a 60ml of EMEM 
with 10 % FCS. Twenty millilitres of the contents of the bottle was aliquoted into 
each flask. The flasks were labelled with the passage number and incubated at 37 °C 
with 5 % CO2 in air. 
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3.1.1.3 Cell count 
 
Cells were trypsinised as described in 3.1.1.2. A viable cell count was then carried out 
using the trypan blue dye exclusion assay. This assay is based on the principle that 
viable cells actively remove the dye from the cell whereas dead cells cannot do that. 
Thus, viable cells remain colourless and hence viable cells can be differentiated from 
dead cells under the microscope. Twenty microlitres of cell suspension and 20 µl of 
0.4 % trypan blue (sigma®) was mixed in a microcentrifuge tube. If cells were too 
concentrated they were diluted with PBS prior to the addition of trypan blue solution 
and the volume of PBS used was noted and included in the dilution factor. A glass 
coverslip was placed on a haemocytometer. The cell suspension mixed with trypan 
blue dye was pipetted under the coverslip on one half of the haemocytometer; this was 
done carefully to make sure that there was no overflow and no air bubbles. The 
number of cells in the four outer grid boxes of the haemocytometer was counted using 
a bright field microscope. The following formula was used to determine the 
concentration of cells per volume unit: 
Concentration of cells (cells/ml) =               n            
Where n = total number of cells counted. 
x 104 x dilution factor 
                                                          No of grid boxes 
 
 
3.1.1.4 Propagation of McCoy cells 
 
To prepare cell culture stock, the cells were trypsinised and stored in McCoy cell 
freezing fluid prepared as described in appendix A. The trypsinised cell suspension 
was transferred to a 15 ml centrifuge tube. The total volume of cells was noted and 
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the same volume of freezing fluid was slowly added, drop by drop to the cells, with 
swirling between the addition of each drop. Aliquots of 1 ml were pipetted into 
cryovials. The cryovials were labelled with the name of the cell line, date and passage 
number. The cryovials sealed with parafilm and placed in polystyrene racks to allow 
slow freezing of the cells and stored in a -70ºC freezer for later use. 
 




Chlamydia trachomatis serovars L1, L2, L3 and E were used in this study. McCoy 
cells were seeded into trak vials with coverslips at a concentration of 8 x 104 cells per 
vial. Before inoculating the cells, one track vial was examined using an inverted 
bright field microscope to check whether the cells were 70-80 % confluent. If so, 
media was aspirated from the remaining vials and replaced with 500 µl chlamydia 
growth medium (see Appendix A). Nine hundred microlitres of sucrose-phosphate 
glutamic acid (SPG) buffer (Appendix A) was added to a microcentifuge tube and 100 
µl of suspension containing the serovar of interest was added.  One hundred 
microlitres of this mix was then added to the trak vial. One hundred microlitres of 
SPG buffer was added to the negative control vial.  To improve contact between 
chlamydia and cells, the vials were centrifuged at 1200 x g for 1 hr. This was 
followed by incubation at 37°C in 5% CO2 in air for 1 hour.  The growth medium was 
aspirated from each trak vial and the monolayer rinsed once with PBS. This was 
replaced with 1 ml of chlamydia growth medium. The infected cells were incubated 
for 48 hours at 37°C in 5% CO2 in air. 
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3.1.2.2 Harvesting of chlamydia 
 
The MicroTrak® C. trachomatis Culture Confirmation Test Kit (Trinity Biotech) was 
used to confirm that the organism had infected and grown in the host cells. This was 
done according to the manufacturer’s instructions. Two of the vials were selected for 
staining, the negative control and one inoculated vial. The media was discarded from 
the 2 vials, 1 ml of 95% ethanol was added and the vials were incubated at room 
temperature on the working surface for 5-10 minutes. The ethanol was aspirated and 
the coverslips were removed and put into wells in a 24-well tissue culture plate.  Five 
hundred microlitres of PBS was added to each vial. Distilled water was pipetted into 
the remaining empty wells to create a humidified environment. PBS was discarded 
leaving a small amount at the bottom. Thirty microlitres of the conjugated anti-
MOMP antibodies was added to each well. A wet paper towel was then placed on top 
of the wells and the plate was closed with a lid. The plate was incubated for 30 
minutes at room temperature and agitated by hand every 10 minutes. The fluid was 
removed and the coverslips were washed with distilled water. The coverslips were 
removed and blotted dry on a paper towel. Coverslips were mounted with the cell 
containing side down on a glass slide using a drop of Distyrene Plasticizer Xylene 
(DPX) - mountant (Sigma®). The slide was allowed to dry and then viewed under a 
fluorescent microscope (Olympus®) with a filter system for fluorescein isothiocynate 
(FITC) (λ =520nm) at magnification 100-400x (dry objective,). Green fluorescent 
chlamydial inclusions confirmed the presence of chlamydia and indicated that the 
organisms could be harvested. This is because the staining solution contains FITC 
conjugated to a monoclonal antibody directed against the major outer membrane 
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protein (MOMP) of C. trachomatis. This antibody binds to C. trachomatis resulting in 
fluorescence. 
 
Chlamydia was harvested as follows.  Media was aspirated from trak vials and 
replaced with 600 μl of SPG containing 10% FCS. Four glass beads were then added 
to each trak vial. The contents of the trak vials were pulse vortexed for 30 seconds. 
Chlamydia was then aspirated and pooled in a 10 ml tube. One hundred and fifty 
microlitre aliquots of chlamydial suspension were then transferred into 
microcentrifuge tubes. The tubes were labelled and stored at -70°C to be used for 
inoculation of endothelial cells. 
 
3.1.2.3 Determination of inclusion body concentration  
 
For determination of inclusion body concentration, McCoy cells were grown in trak 
vials and inoculated with 10-fold serial dilutions of each isolate (L1, L2, L3 and E) 
from the stored stocks (3.1.2.2). Dilutions ranged from 10-1 to 10-4 . Each dilution was 
inoculated in triplicate. After 48 hours, monolayers were stained by using the C. 
trachomatis culture confirmation kit as described above. The slides were then viewed 
under the fluorescent microscope. A dilution of each serovar in which the number of 
inclusions could be counted without difficulty was chosen. Counts of inclusions were 
carried out at 200X magnification.  Twenty fields of view were counted for each 
triplicate. The results were then averaged and the concentration determined using the 
following formula: 
Concentration (IFU/ml) = n x 1000μl
n = average no. of inclusion bodies 
 x conversion factor x dilution factor 
                                                 100μl 
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See appendix B for a list of conversion factors. 
 




HUVEC was cultured in 25 cm2 culture flasks and maintained in endothelial growth 
medium-2 (EGM-2) (Clonetics®). The EGM-2 medium was aseptically reconstituted 
by adding the entire contents of each supplement vial to 500 ml of the medium. The 
supplements added were 2 ml FBS, 0.5 ml gentamicin sulphate, amphotericin-B (GA-
1000), 0.5 ml ascorbic acid, 0.5 ml recombinant long R Insulin-Like growth factor-1 
in aqueous solution (R3 – IGF -1), recombinant human endothelial cell growth 
factor(rhEGF) in a buffered bovine serum albumin (BSA) saline solution, 0.5 ml 
recombinant human vascular endothelial growth factor (VEGF), 2.0 ml recombinant 
human fibroblast growth factor-B (rhFGF-B), 0.5 ml of heparin and 0.2 ml 
hydrocortisone (these supplements were Clonetics Clonetics® products). A 25 cm2 
flask with 5 ml of endothelial growth medium was placed in a humidified incubator at 
37°C in 5% CO2 in air for 30 minutes to achieve equilibrium between fluid and gas 
phase. A cryovial containing HUVEC (3.1.3.2) was thawed in warm water and 
emptied into the flask. The culture was incubated at 37°C with 5% CO2 in air. The 






3.1.3.2 Subculturing of HUVEC  
 
All ingredients were brought to room temperature. Spent media was aspirated from 
the flask containing the HUVEC culture. The cells were then rinsed with 5 ml of 
HEPES- buffered saline (HEPES-BSS), to remove remaining media which contains 
complex proteins that neutralise the action of trypsin. Trypsinisation was performed 
as described in 3.1.1.2. The cells were then transferred to a 15 ml centrifuge tube. The 
flask was rinsed with the remaining 2 ml of HEPES-BSS to harvest any residual cells 
and the contents added to the centrifuge tube. To determine whether the cells have 
been successfully harvested the flask was observed under the inverted microscope and 
was expected to have less than 5% of cells left. The cell suspension was centrifuged at 
220 x g for 5 minutes. The supernatant was aspirated leaving about 200 µl in the well, 
in which the cells were resuspended. The cells were then diluted with 2 ml of growth 
media.  
The viable cell count was determined using trypan blue exclusion as described 
(3.1.1.3). The number of viable cells was then used to determine the total number of 
flasks to inoculate using the following equation: 
 
Total no. of flasks to inoculate =           
Five millilitres of growth media was transferred to each of the flasks and the required 
volume of cells suspension was added to each of them.  The flasks were labelled with 
the passage number and cell type and incubated in a humidified chamber at 37°C with 
total no. of viable cells 
                                                       growth area x seeding density 
 
The seeding density is recommended by the provider of the cell line (ATCC) and is 
defined as the number of cells allowed per surface area at the point of seeding. It 
differs per cell line. The growth area is the total surface area of the flask. 
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5% CO2 in air. Media was replenished every two days. When cells reached 
confluency they were trypsinised and then frozen in HUVEC freezing fluid 
(Appendix A) in 500 ml volumes.  
 
 
3.2 CHEMOKINE AND ADHESION MOLECULE ASSAYS 
3.2.1 Infection protocol 
 
HUVEC were seeded in 24-well plates and allowed to become confluent prior to 
infection. The number and viability of cells was determined by trypsinising the cells 
in one well for each run and performing the trypan blue dye exclusion assay as 
described in 3.1.1.3. Cells were then infected with each of the C. trachomatis serovars 
at an MOI of 1. Three wells of HUVEC were also treated with 500 U of human 
recombinant tumor necrosis factor alpha (TNF-α) (formulation: 10 mM sodium 
phosphate, pH 7.2, 150 mM NaCl, with BSA, 0.22 µM filtered, eBioscience) per ml 
which served as a positive control for the quantification of production of chemokines 
and the adhesion molecule (IL-8, MCP-1 and ICAM-1). The negative control 
comprised uninfected cells. Mock infected cells i.e. HUVEC treated with lysates of 
uninfected McCoy cells were also included as a control; this is because the chlamydia 
inoculum used for the experiments will have contained remnants of McCoy cells since 
it was propagated in McCoy cells. 
 
The chlamydia strains were diluted with SPG to achieve the required MOI. Nine 
hundred microlitres of chlamydia growth medium (see Appendix B) was added to the 
wells containing HUVEC cells. HUVEC were inoculated separately with 100 µl of 
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each strain of C. trachomatis. Hundred microlitres of SPG was added to the negative 
control well. To facilitate infection chlamydia-cell contact was enforced by 
centrifugation at 1200 x g for 1 hour, followed by incubation for 1 hour at 37°C with 
5% CO2 in air. Following incubation, the medium was aspirated, cell monolayers 
were washed with Hanks’ balanced salt solution (HBSS) (Clonetics®), and fresh 
chlamydia growth medium was added to the cultures. Uninfected, mock-infected, 
TNFα treated and infected cells were incubated at 37°C with 5% CO2 in air before 
chemokine assays were performed. 
 
After 24 hours, supernatants were collected and stored at -80°C until used to measure 
levels IL-8 and MCP-1 by commercially available enzyme-linked immunosorbent 
assay (ELISA) kits. 
 
3.2.2 Monocyte Chemotactic Protein – 1 ELISA 
 
Measurement of MCP-1 production by chlamydia infected HUVEC was carried out 
using the MCP-1 ELISA kit (DIACLONE) according to the manufacturer’s 
instructions. All reagents were made according to the manufacturer’s instructions (see 
Appendix C) Two-fold dilutions of the standard were prepared in duplicate. All 
experimental wells were in triplicates. Eighty microlitre of assay buffer (provided 
with the kit) was added to the experimental wells followed by 20 µl supernatant from 
the chlamydia infected cells or controls. Fifty microlitre of HRP conjugate was then 
added to all the wells. The plate was then covered and incubated at room temperature 
(18°C-25°C) for 1 hour. The wells were emptied and washed thrice with wash buffer. 
After the last wash the plate was blotted with paper towel. One hundred microlitre of 
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tetramethylbenzidine (TMB) Substrate Solution was added to all wells and the plate 
was covered with aluminium foil and incubated for 8 minutes at room temperature. 
The reaction was stopped by adding 100µl of stop solution to each well. Absorbance 
readings were measured at 450 nm as the primary wavelength and 620 nm as the 
reference wave length, using an Anthos 2010 ELISA reader. 
 
3.2.3 Interleukin -8 ELISA  
 
The IL-8 ELISA was also carried out according to the manufacturer’s instructions 
using the IL-8 ELISA kit. The procedure was the same as the MCP-1 one except that 
a 100 µl of supernatant from each serovar was added to sample wells and 100 µl of 
reconstituted control vial was added in duplicate to control wells H1 and H2. One 
hundred microlitres of diluent was also added to the blank wells. Biotinylated anti IL-
8 was prepared and 50 µl of this solution was added to all wells. The cells were then 
covered with a plate cover and incubated for 1 hour at room temperature. 
Streptavidin-HRP solution was prepared and 100 µl of this was added to all wells, the 
plate was covered and incubated for 30 minutes at room temperature. Unlike the 
MCP-1 ELISA, after addition of TMB solution, the plate was incubated for 12 
minutes instead of 8 minutes. 
 
3.2.4 Cell surface Intercellular Cell Adhesion Molecule-1 ELISA 
 
The same infection protocol as for the chemokine assays was carried out (see 3.2.1). 
The difference was that 96-well plates were used, so 10 µl of each C.trachomatis 
serovars prepared in 3.1.2 was used to infect HUVEC at an MOI of 1.  The adhesion 
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molecule ELISA was carried out as indicated by Al-Numani et al. (2003) and Krüll et 
al. (1997) as follows. All incubation steps were carried out at room temperature. 
After incubation the serovars and controls were aspirated and the monolayer was 
fixed with 1% paraformaldehyde for 20 minutes. The paraformaldehyde was aspirated 
and cells were washed with PBS. The cells were then blocked with 1% FCS in PBS. 
An antibody against the adhesion molecule ICAM-1 (anti-human1CAM-1) purchased 
from R&D Systems, Minneapolis, USA, was the added at a concentration of 50 µg/ml 
and the plate was incubated for 1 hour at room temperature. Plates were washed three 
times with PBS and then exposed to horseradish peroxidase-conjugated goat 
antimouse IgG antibody( R& D Systems, Minneapolis, USA) for 30 minutes. 
Detection of the bound enzyme was carried by incubating with a 1:1 solution of TMB 
and hydrogen peroxide for 10-20 minutes. Absorbance was read at 450 nm. 
 
3.2.5 Calculation of Results  
 
The average absorbance of the standards and samples was calculated for the IL-8 and 
MCP-1 ELISAs. The standard curve was then created by plotting average absorbance 
of standards against the respective cytokine concentration. The best fit line was then 
drawn through the points. This curve was used to determine the concentration of the 
mean absorbance values of the samples. Since experiments had varying inoculation 
concentration, all results were expressed per 100 cells. For the ICAM-1 ELISA, the 
average absorbance of each serovar was calculated. All the results were then analysed 
using one way analysis of variance with Turkey’s post test (Graphpad Instat) as 




3.3 TRANSENDOTHELIAL MIGRATION ASSAY 
Transendothelial migration of leukocytes is a complex multistep process initiated by 
inflammatory mediators. It occurs when leukocytes migrate through the endothelium 
into the infected tissue. The assay was carried out as described by Molestina et al. 
(1999). It quantifies the number of neutrophils and monocytes that migrate during a 
fixed time period through a confluent monolayer of endothelial cells. The 
transendothelial migration induced by C. trachomatis serovars was investigated 
through a series of steps as described below.  
HUVEC were seeded on 6.5-mm Transwell-Clear inserts at a density of 4 × 105 
cells/insert. These inserts were placed in the tissue culture wells containing growth 
medium and these were incubated to allowed the cells to reach confluency before 
infection. The formation of confluent monolayers was verified by silver nitrate stain 
and microscopic examination under a 40× objective.  
 
3.3.1 Silver Nitrate staining 
 
This was carried out on one transwell. Growth media was discarded from the well and 
the monolayer was rinsed with RPMI containing 10% FBS. The monolayer was 
treated with 0.25% silver nitrate (AgNO3) (kindly donated by the Department of 
Mycotoxins) in distilled water for 40 seconds, rinsed with 5% glucose, then fixed with 
4% formaldehyde. The stained monolayer was exposed to UV light by putting the 
transwell in the safety cabinet with the UV light on for 5 minutes to intensify the 
stain. The cells were then observed under an inverted microscope with a 40x objective 
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lens. The confluent monolayer was photographed using the Olympus CMOS color 
camera with Analyse® getIT software. 
 
3.3.2 Infection protocol 
 
HUVEC monolayers in 6.5-mm transwells were infected separately with each isolate 
of C. trachomatis suspended in inoculation medium. The cells were inoculated with 4 
× 105 inclusion-forming units (IFU) per well, resulting in a MOI of 1. The inoculation 
media was the same as the one used to inoculate McCoy cells except cycloheximide 
was not added. Media was removed from transwells and they were washed with 100 
µl of PBS. The PBS was discarded and replaced with 90 µl of chlamydia growth 
media. Ten microlitres of SPG (pH 7.5) containing the appropriate amount of each 
serovar of C. trachomatis to achieve an MOI of 1 was added the appropriate wells. 
Also included were the negative controls consisting of sterile SPG and SPG 
containing lysed McCoy cells as well as a positive control consisting of TNFα. 
Infection was performed by incubation for 2 h at 37°C with 5% CO2 in 95% air. 
Following incubation, the medium was aspirated, the cell monolayers were washed 
with Hanks’ balanced salt solution (HBSS) (Clonetics®) and fresh inoculation 
medium was added to the cultures. The plates were then incubated for 24 hours before 
the transendothelial migration assay. 
3.3.3 Isolation of human neutrophils and monocytes  
For isolation of peripheral blood mononuclear cells (PBMC) and neutrophils, 50 ml of 
blood was collected from healthy volunteers using a sterile syringe.  Blood was 
collected in 9 ml EDTA tubes.  
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PBMC and neutrophils were isolated from whole blood using Histopaque gradient 
density centrifugation under sterile conditions. Histopaque-1077 and 1199 were 
warmed to room temperature before use.  Twelve millilitres of Histopaque 1119 was 
added to a 50 ml centrifuge tube. An equal volume of Histopaque-1077 was carefully 
layered onto the Histopaque-1119. Twenty-four millilitres of whole blood was then 
carefully layered onto the upper Histopaque layer. The tube and its contents were 
centrifuged at 700 x g for 30 minutes at room temperature. Six distinct layers were 
observed after centrifugation. Layer A contained the PBMC and layer B contained the 
neutrophils (figure7).  
                                                                
Figure 7
The top layer was aspirated to within 0.5 cm of layer A using a Pasteur pipette and 
discarded. The layer A cells were transferred into a 15 ml centrifuge tube labelled 
: Demonstration of the layers obtained before and after centrifugation during 













PBMC. The Histopaque-1077 layer was aspirated and discarded to within 0.5 cm of 
layer B. The layer B cells were transferred to a 15 ml centrifuge tube labelled 
neutrophils. The cells in both tubes were washed with isotonic PBS. Ten millilitres 
PBS was added and the tubes were centrifuged for 10 minutes at 200 x g. After 
centrifugation the supernatant was discarded and the cells were resuspended by gentle 
aspiration with a Pasteur pipette. Cells were washed 3 time altogether. The cells were 
then resuspended in chlamydia growth medium (CGM). To determine the 
concentration of cells a cell count was carried out using the trypan blue dye exclusion 
assay and a haemocytometer. 
 
3.3.4 Transendothelial migration assay 
 
After 24 hours of infection, the media from the upper and lower chambers of the 
transwells was aspirated. The endothelial layer was then washed three times with 
HBSS. To one 24 well plate set up for the neutrophil migration assay, neutrophils 
were added to the upper chamber at a density of 4 x 106. Fresh medium was also 
added to the lower chambers. The plate was then incubated for 30 minutes at 37 oC in 
5% CO2 in air. To the plate labelled monocytes, monocytes were added to the upper 
chamber at the same density as neutrophils. The lower chambers were also filled with 
600 µl of fresh medium. This plate was incubated for one hour. Cells were added to 
all transwells including the control transwells.  
 
Following incubation, the upper chambers from both plates were removed. Cells 
counts were done on each well (lower chamber media) immediately using the 
haemocytometer and the trpyan blue dye exclusion assay. Each well was swirled 
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before taking out the required amount of cells to allow equal distribution of cells 
throughout the well. After the counts the number of cells which migrated was 
determined using the formula in 3.1.1.3 which gave the concentration of cells in 1 ml 
of media. To find the number of cells in 600 µl which is the amount of media in the 
lower chamber the concentration was multiplied by 0.6 ml. 
 
 
3.4 LACTATE DEHYDROGENASE RELEASE CYTOTOXICITY ASSAY 
3.4.1 Infection protocol 
 
HUVEC were seeded on 24-well plates at a density of 4.0 x 105 and allowed to adhere 
until confluent. Cells were monitored by doing cell counts until they reached a density 
of 4.0 - 4.5 x 105 . Inoculation of cells in 24 well plates for the cytotoxicity assay was 
carried out as for the chemokine assays with MOI of 1. In addition to the experimental 
wells, 500 U of TNFα was used as a positive control, mock infected and uninfected 
cells were also included as controls. After infection the plate was incubated for 24 
hours at 37°C with 5% CO2 in air. 
 
3.4.2 Lactate Dehydrogenase Release Assay 
 
When the  cell membrane looses its integrety, the cell releases the cytosolic enzyme 
lactate dehydrogenase (LDH). The CytoTox 96 ® Non-Radioactive Cytotoxicity 
Assay kit (Promega) was used to quantify the level of LDH released into the 
supernatant by a coupled enzymatic assay. This assay converts tetrazolium salt into a 
red formazan product. The intensity of the colour change is directly proportional to 
 51 
the number of lysed cells (Moravec, 1994). The assay was carried out according to the 
manufacturer’s instructions, except that the lysis solution was prepared in-house.  The 
lysis solution supplied with the kit (9% Triton X-100) was insufficient to produce 
100% LDH release in this experiment, but 15% Triton X-100 in triple distilled water 
did. The Substrate mix was reconstituted using the assay buffer. The assay buffer was 
allowed to come to room temperature in the dark. Twelve millilitres of assay buffer 
was then added to a bottle of Substrate mix. The solution was mixed gently by 
inverting to dissolve the substrate. Unused reconstituted substrate mix was tightly 
capped and stored at -20 °C for ≤ 8 weeks.  
 
Forty-five minutes before collection of supernatants, 100 µl of lysis solution was 
added to a set of triplicate wells with HUVEC monolayers and designated Target Cell 
Maximum LDH Release. Another 100 µl was added to triplicate of wells with media 
only i.e. without cells. This was to correct for the volume increase caused by the 
addition of lysis solution and was designated Volume Correction Control. Also 
included was a triplicate of wells containing culture medium to correct for 
contributions caused by phenol red and LDH activity that may be present in serum-
containing culture medium and this was designated Culture medium Background.  
After 24 hours of incubation the plate was centrifuged at 250 x g for 4 minutes. 
Supernatants were collected and used to determine the cytotoxicity levels. 
 
Fifty microlitres of supernatants of each sample was transferred to the corresponding 
well on a 96 well plate. Fifty microlitres of the reconstituted substrate mix was added 
to each well. The plate was covered with aluminium foil and incubated at room 
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temperature for 30 minutes. The reaction was stopped by adding 50 µl of stop solution 
to each well. Absorbance was read immediately at 490 nm using a spectrophotometer. 
 
3.4.3 Calculation of Results 
 
The culture medium background average absorbance was subtracted from all values 
of experimental and the target cell spontaneous LDH release, i.e. the negative control 
with uninfected cells. The Volume Correction Control average absorbance was 
subtracted from the average absorbance values of the Target Cell Maximum LDH 
Release Control. The above corrected values were then used to calculate the % 
cytotoxicity for each experimental well using the following formula: 
% Cytotoxicity = Experimental-Target Spontaneous       x 100   (Appendix D) 
                           Target Maximum-Target Spontaneous 
 
Results were then analysed using one way analysis of variance with Turkey’s post test 
(Graphpad Instat; see 3.5). 
 
The ELISA, transendothelial migration and cytotoxicity assays results were 
statistically analysed using Graphpad Instat version 3.00(Appendix E). Significance 
between standard deviation of groups was determined using Bartlett’s test. Gaussion 
distribution was tested using the Kolmogorov and Smirnov to confirm whether data 
was parametric or not. When data was confirmed to be parametric then Oneway 
Analysis of Variance (ANOVA) was used. The transendothelial migration assay 
3.5 STATISTICAL ANALYSIS 
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3.6 APOPTOSIS ASSAYS 
Analysis of cell death was carried out using two methods, i.e the modified 
CaspGLOWTM Flourescein Caspase Staining kit (BioVision - BiocomBiotech) and 
the modified DeadEndTM Colorimetric TUNEL System from Promega. 
 
3.6.1 CaspGLOWTM Flourescein Caspase Staining Assay 
 
Caspases (2, 3, 6, 7, 8, 9 & 10) are involved in apoptosis (Creagh et al., 2003). The 
CaspGLOWTM Fluorescein Caspase Staining kit (BioVision - BiocomBiotech) is 
based on conjugation and proteolysis of tetrapeptide substrates with caspase cleavage 
sites. This assay uses the caspase family inhibitor Val-Ala-Asp-α-fluoromethylketone 
(VAD-FMK) conjugated to fluorescein isothiocynate (FITC) forming a product 
known as FITC-VAD-FMK as a marker. 
 
3.6.1.1 Infection protocol 
 
HUVEC were grown on glass coverslips in 24-well tissue culture plates and allowed 
to reach confluency. After a cell count with trypan blue dye, cells were then infected 
with C. trachomatis serovars L1, L2, L3 and E at a MOI of 1. Infection was carried 
out as for the chemokine assays. Also included were the positive control TNFα, the 
negative control where only SPG (pH 7.5) was added and mock infected wells. For 
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the assay kit, etoposide at a concentration of 20 µM was used as a positive control. 
The etoposide was added to wells containing HUVEC 4 hours before the assay. 
Infected cells were incubated for 24 hours after which the apoptosis assay was carried 
as described below: 
 
3.6.1.2 Analysis of Cell death 
 
Analysis of cell death was carried out using the CaspGLOWTM Flourescein Caspase 
Staining kit (Biovision-BiocomBiotech) with modification because the kit was 
designed for suspension cells whereas HUVEC are not. The kit was modified as 
follows: media was aspirated from the wells and 300µl of CGM + 1 µl FITC-VAD-
FMK was added to the wells. The cells were incubated for 0.5-1 hour. Media was 
aspirated and cells were washed with wash buffer for 5 minutes. The cells were then 
fixed with10% formaldehyde in wash buffer for 5 minutes. A final wash with wash 
buffer for 5 minutes was done. Slides were then prepared by placing coverslips cell 
side down on glass slides with a drop of buffer. Cells were observed under a Nikon 
eclipse E600 fluorescent microscope and photographed using a Nikon ColorView 
Soft Imaging System digital camera. Comparisons were made of the different serovars 
and the controls. 
 
3.6.2 DeadEndTM Colorimetric TUNEL System Assay 
 
The DeadEndTM Colorimetric TUNEL System (Promega) was used to analyse cell 
death by measuring one of the characteristics of apoptotic cells which is nuclear DNA 
fragmentation. The terminal deoxynucleotidyl transferase recombinant (rTDT) 
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enzyme is used to incorporate the 3`-OH DNA ends with a biotinylated nucleotide. 
Horse radish peroxidase (HRP) labelled streptavidin binds to the biotin on the 
nucleotide and the HRP label is detected using diaminobenzidine (DAB) stain 
solution. This results in dark brown apoptotic nuclei.  
 
3.6.2.1 Infection protocol 
 
Seeding of HUVEC and infection with chlamydia was carried out as for the TUNEL 
assay. The TUNEL positive and negative controls were provided with the kit. The 
procedure was carried out according the manufacturers instructions and modifications 
by Joubert, (2009) as follows: 
 
3.6.2.2 Analysis of Cell death 
 
The second analysis of cell death was carried out using the DeadEndTM Colorimetric 
TUNEL System (Promega). The assay was carried out according to the manufacture’s 
instructions wit some modifications to fit our setting.  
Instead of processing cells on slides as stated by the manufacturer, cells were 
processed on coverslips which were within the wells of a 24 well plate. The coverslips 
were only mounted to glass slides after the staining procedure. Processing of the cells 
was done at room temperature unless otherwise stated. The procedure was as follows: 
Cells were washed with PBS and fixed with 4% formalin in PBS for 25 min instead of 
the recommended 10% formalin in PBS by the manufacturer. The cells were then 
washed twice with PBS for 5 min. Permeabilization was done by incubation with 
0.4% Triton® X-100 in PBS for 10 min 37°C instead of the 0.2% recommended by the 
 56 
manufacturer. Prior work done in the department of Medical Microbiology, 
University of Kwa-Zulu Natal by Joubert in 2009 had shown that the recommended 
concentration of Triton® X-100 did not sufficiently permeabilize the HaCaT 
keratinocytes. Cells were washed twice with PBS for 5 min. The DNase TUNEL 
positive control (10units/ml RQ1 DNase) was then treated by the following steps: 
washed with 200 µl DNase I buffer for 5 min, treated with 200 µl RQ1 RNase free 
DNase (10 units / ml) (Promega) in DNase I buffer for 10 min at 37°C, rinsed 4 times 
with tdH2O and then washed with PBS for 5 min. Equilibration was done with 100 µl 
equilibration buffer for 5-10 minutes. Recombinant Terminal Deoxynuclotidyl 
Transferase (rTdT) reaction mix was prepared by mixing the following components 
per well: 98 µl equilibration buffer, 1 µl biotinylated nucleotide mix and 1 µl rTdT 
enzyme or 1 µl autoclaved tdH2O for the TUNEL negative control. Cells were 
labelled with 100 µl rTdT reaction mix for 60 min at 37°C. To prevent evaporation 
and ascertain that the reagent is evenly distributed during the labelling procedure each 
glass coverslip was covered with a plastic coverslip. The plastic coverslips were 
removed and the reaction stopped with 200 µl 2X Sodium-Saline Citrate (SSC) for 
15 min. washing was done thrice with PBS for 5 min. Endogenous peroxidases was 
blocked with 0.3% hydrogen peroxide for 4 min. Then another wash three times with 
PBS for 5 min was done. Binding with 200 µl streptavidin horse radish peroxidase 
(HRP) (1:500 in PBS) for 30 min and washing thrice with PBS (pH 7.4, Oxoid) for 
5 min then followed. Diaminobenzidine (DAB) stain solution was then prepared by 
adding 950 µl tdH2O, 50 µl 20X DAB substrate buffer, 50 µl DAB 20X chromagen 
and 50 µl 20X hydrogen peroxide. The 100 µl DAB solution was used to stain each 
glass coverslip for 15 minutes covered with a plastic coverslip for reasons already 
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mentioned above. Plastic coverslips were then removed and the monolayer was rinsed 
5 times with tdH2O.  
 
Counterstaining of the slides with the MicroTrak® C. trachomatis Culture 
Confirmation Test Kit was done at the end of the TUNEL assay staining procedure. 
Briefly, the slides were moistened with PBS (pH 7.4, Oxoid) for 5 min and stained 
with 30 µl stain reagent for 30 min at 37°C in a humidified chamber with shaking 
every 10 minutes. The monolayer was then washed with tdH2O for 10 sec. Glass 
coverslips were removed from the wells and blotted on a paper towel. Coverslips were 
finally mounted to glass slide with DPX mounting fluid and left to dry. 
  
The slides were viewed with a Nikon eclipse E600 fluorescent microscope.   Bright 
field was used to examine identify cells with fragmented DNA and DAB positive 
nuclei; The mode was then switched to fluorescence (excitation wavelength 450-490 
nm; emission wavelength 520 nm) to identify the apple green C. trachomatis as 
confirmation that the cell were indeed infected  with C. trachomatis. The slides were 
photographed using the Nikon ColorView Soft Imaging System digital camera. 








CHAPTER 4: RESULTS 
 
            
4.1 Infection of HUVEC with chlamydial serovars 
All Chlamydia trachomatis serovars (L1, L2, L3 and E) successfully infected and 
replicated in HUVEC (Figure 8).  
 
     




Figure 8: Micrographs of uninfected HUVEC 
(A), LGV C.trachomatis serovar L2 (B) and 
Ocular Genital serovar E(C). Note the typical 
flat pavement like structure of endothelial 
cells with the absence of the green 
fluorescent staining in the uninfected cells 
compared to the apple green chlamydial 
inclusions after 24 hours incubation and 
staining with MicroTrak® C. trachomatis 
Culture Confirmation Test Kit and viewed at 
400X under a fluorescent microscope. The 
green fluorescent chlamydial inclusions 



































4.2 Chemokines and Adhesion Molecules Assays 
 





IL8 production by the different serovars is shown in figure 9. Only L3 stimulated 
significantly higher production of IL-8 (p<0.001) as compared to the negative 
controls (cells mock-infected with lysed uninfected McCoy cells or unexposed 
HUVEC cells) (Appendix E). There was no significant difference in the production of 
IL-8 between the other LGV biovars (L1 and L2) and ocular genital serovar E and the 
negative controls (p>0.05). L3 also stimulated a significantly higher production of IL8 
as compared to the other serovars (L1, L2 and E, with p<0.001, p<0.001 and p< 0.01 
respectively (Appendix E).  
 
Figure 9: Mean levels of IL-8 induced in HUVEC infected with different C. 
trachomatis serovars and controls after 24 hr of incubation, expressed per 100 cells. 
Bars indicate the means ± standard errors of the means of three separate experiments 
performed in triplicates.   
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MCP-1 production by chlamydia exposed HUVEC is shown in figure 10. L3 
stimulated significantly higher amount of MCP-1 compared to the negative and the 
mock infected cells (at p<0.001 and p<0.05 respectively). There was also no 
significant difference in the levels of MCP-1 produced between the remaining LGV 
(L1 and L2) and the OG strain. The LGV strains also did not differ significantly 
amongst each other in the production of MCP-1 at a p value of > 0.05(Appendix E).  
 
Figure 10: Mean levels of MCP-1 induced in HUVEC infected with different C. 
trachomatis serovars and controls after 24 hr of incubation, expressed per 100 cells. 
Bars indicate the means ± standard errors of the means of three separate experiments 
performed in triplicates.   
 
After 24 hour incubation of C. trachomatis infected HUVEC, the level of expression 
of ICAM-1 was measured on the 96 well plates. Only L3 showed a significant 
expression of ICAM-1 compared to the negative control and cells exposed to 


































remnants of McCoy (p<0.05 and p<0.01 respectively). However, the remaining LGV 
serovars and the E serovar showed no significant difference in the expression of 
ICAM-1 when compared to the controls (all at p>0.05). L3 also significantly 
expressed more ICAM-1 adhesion receptors on HUVEC as compared to the L2 
(p<0.05). There was no significant difference between L1, L2 and E at p value of 





Figure 11: Mean levels of ICAM-1 expression by HUVEC infected with C. 
trachomatis serovars infected HUVEC and controls. Quantification was done after 24 
hr of incubation. Bars indicate the means ± standard errors of the means of three 






























4.3. Transendothelial migration assay 
 
Three separate experiments were done for the transendothelial migration of 
neutrophils and monocytes and the results are shown in figure 13. Although the 
differences in the number of migrated neutrophils between untreated HUVEC, mock 
infected HUVEC and HUVEC infected with chlamydia serovars (Appendix E) did not 
reach statistical significance (> 0.05), there appeared to be a trend towards a stronger 
neutrophil migration with the LGV serovars. L3 induced the highest level of 
neutrophil migration compared to the other serovars. The OG serovar E showed the 
same migration level as the mock infected cells.  
 
Statistical analysis of monocytes transendothelial migration showed that HUVEC 
infected with L3 had significally higher amount of migrated monocytes than the 
controls. L2 infected HUVEC also had a significally higher number of migrated 
monocytes compared to the negative control. All the LGV serovars had a higher 
number of migrated monocytes than the OG serovar. The OG serovar E did not show 
any significant stimulation of migration of monocytes as compared to the negative 




























Figure 12: A confluent monolayer of 
HUVEC grown in transwells for 
transedothelial migration assays.(A) Cells 
were stained using the silver nitrate stain 
,which form silver grains at the 
intercellular junctions (arrow) and 
observation was done under an inverted 
light microscope to confirm that the cells 
are confluent. Magnification X200.  
: Mean number of migrated monocytes and neutrophils through HUVEC 
infected with different C. trachomatis serovars and controls after 24 hr of incubation. 





















4.4. Cytotoxicity assay 
 
Cell death due to necrosis of HUVEC infected with C. trachomatis serovars was 
analysed using the LDH assay kit. The average percentage cytotoxicity of the serovars 
and controls is shown in figure 14. Only L3 had significantly higher percentage 
cytotoxity than the negative control (p<0.05) but not with the mock infected cells 
(p>0.05). There was no significant difference between the controls and the rest of the 
LGV serovars and the OG serovar E, all at p value of >0.05. The cytotoxity effect of 
OG serovar E on HUVEC was not significantly different to the LGV serovars (all at a 




Figure 14: Mean levels of percentage cytotoxicty of HUVEC infected with different 
C. trachomatis serovars and controls after 24 hr of incubation. Cytotoxicty was 
measured by quantifying the level of LDH released from cells. Bars indicate the 
means ± standard errors of the means of three separate experiments performed in 




Comparison of the bright field micrographs with fluorescent micrographs showed a 
light brown staining where the infected cells are positioned( blue circles) which might 
mean that the DNA was starting to fragment, hence if given enough time there might 
have been apoptosis since this assay was done after only 24 hours of incubation. 
There appeared to be no difference between numbers of dark brown stained DAB 
positive nuclei on uninfected cells compared to the chlamydia infected cells. The only 
difference was the presence of the faint light brown larger stains on infected cells 
which were not present on uninfected cells. There appeared to be no difference in the 
4.5 Apoptosis assay 
 
 
4.5.1 DeadEndTM Colorimetric TUNEL System Assay 
 
 
TUNEL assay was used to assess cell death on endothelial cells infected with 
HUVEC serovars.The DNase treated  positive control exhibited some brown stained 
nuclei(figure 15A), whereas the TUNEL negative (TdT free) control showed no dead 
cells(figure 15B). The uninfected negative control (figure 15C) showed some DAB 
positive nuclei, however these were darker and smaller than those observed in the 
DNase positive treated control. 
 
Micrographs of HUVEC infected with different serovars were taken, at bright field to 
show the TUNEL stained nucleus and the same field of view was used to take 
micrographs of chlamydial infected cells with fluorescence view (figure 16A, B, C, D 
and figure 17A, B, C and D). The small brown stained DAB positive nuclei similar to 
the ones found on the uninfected negative controls were observed in all the serovars 
which might be attributed to normal cell turnover hence apoptosis (indicated by white 
arrows).  
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number and appearance of DAB stained nuclei amongst the LGV (L1-L3) and Ocular 
genital serovars (E) 
            
 
            
 
Figure 15: HUVEC monolayers TUNEL assay controls. (A) Positive control treated 
with DNAse. Note the dark brown stained nuclei indicating of apoptosis. (B)-TUNEL 
negative control (TdT free) with no apoptotic cells (C) uninfected control and (D) 





             
                      
Figure 16:  Micrographs of TUNEL stained HUVEC infected with chlamydial serovar 
L1 (A and B) and L2 (C and D). The micrographs on the left are fluorescent 
micrographs, the ones on the right are the same field of view bright field TUNEL 
micrographs. The small dark brown stained nuclei similar to the ones present in the 
uninfected negative control were present in both the serovars (arrows). The blue 
circles show the position of inclusion bodies and the corresponding position on the 
left micrographs, note the light brownish staining, this might show that the DNA was 






       
       
Figure 17: Micrograph of TUNEL stained HUVEC infected with chlamydial serovar 
L3 (A and B) and E (C and D), 24 hours post exposure. The micrographs on the left 
are fluorescent micrographs and on the right are the same field of view bright field 
TUNEL micrographs. The small dark brown stained nuclei is also present here 
(arrows), and the light brownish staining is also present on the corresponding position 




4.5.2 CaspGLOWTM Flourescein Caspase Staining Assay 
 
Caspase Staining kit was used to confirm cell death by apoptosis after 24 hours of 
incubation (figure 18). The caspase positive cells in the well treated with etoposide 
(positive control) were evenly distributed over the coverslip (figure 18A), while the 
caspase positive cells in the other wells appeared to cluster (figure 18B-G). This 
clustering and subsequent uneven distribution effect made it difficult to count the 
number of caspase positive cells. It seemed that there was not much of a difference 
between caspase positive cells of the controls and chlamydia infected cells and also 
amongst the serovars. This suggests that death as observed here is due to the normal 



















                                  

















Figure 18: Micrographs of Caspase stained 
HUVEC. A is positive control (20µM 
etoposide), notice the evenly distributed 
caspase positive cells( Original Magnification 
X200) , B is the negative control, C is the 
mock infected cells, D-G are L1, L2, L3 and E 
chlamydial serovars infected cells respectively. 
There appeared to be no observable difference 
amongst the serovars, and also between 
HUVEC infected with chlamydia and the 
negative and mock infected control. One 
noticeable feature was that Caspase positive 
cells appeared in clusters in all experimental 
wells except for the positive control. Original 
magnification X100. 
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Most studies investigate C. trachomatis infection of other cell lines such as HeLa and 
McCoy cell line (Ward et al, 1998). However recently, studies have emerged that 
looked at activation of endothelial cells. Most of these investigate the presence of 
inclusion bodies after 48 hours and with the use of a cell replication inhibitor like 
cyclohexamide (Ward et al, 1998). We studied the growth of chlamydia without such 
inhibitors since this reflects what happens in vivo more closely. We found 
intracellular inclusion body-like structures as early as 24 hours after infection (figure 
8). Thus C. trachomatis is able to attach to and infect HUVEC, get internalized, 
transforms into reticulate bodies, replicates and form inclusion bodies within 24 hours 
of exposure. These results correlate with those by Krüll et al. (2004) who also showed 
CHAPTER 5: DISCUSSION 
 
 
This study aimed to contribute to the understanding why infection with C. 
trachomatis, biovar LGV results in different pathology as compared with infection 
with the OG biovar. This was approached by comparing responses of HUVEC to the 
different LGV serovars with the response to a single OG serovar. 
 
To confirm whether C. trachomatis LGV and OG strains do infect and replicate in 
HUVEC , confluent HUVEC grown in glass slides were infected with C. trachomatis 
L1,L2,L3 and E at an MOI of 1 and  stained with MicroTrak® C. trachomatis Culture 
Confirmation Test Kit 24 hours post exposure. Both the LGV and OG C. trachomatis 
serovars successfully infected and replicated in HUVEC, as proven by the presence of 
inclusion or reticulate bodies  which occur after the bacteria has infected the cell as an 
elementary body transform to a reticulate body which is the replicative phase of the 
life cycle. This shows that C. trachomatis can infect endothelial cells.  
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that C. trachomatis was able to infect and replicate and form inclusion body-like 
structures in HUVEC 24 hours post exposure. They had a higher percentage of 
infected cells but this can be attributed to the higher MOI used (MOI=5 versus 
MOI=1). 
 
Knowing that the bacterium was able to infect HUVEC, the next step was to establish 
whether it does activate and cause an acute inflammatory response by producing 
proinflammatory chemokines and increase expression of adhesion molecules leading 
to leukocyte recruitment and transendothelial migration. The acute inflammatory 
response to chlamydial infection is characterised by migration of neutrophils to the 
site of infection followed by monocytes (Stephens, 2003). IL-8 chemokines are 
specific for recruiting neutrophils whereas MCP-1 chemokines are specific for 
monocytes. Adhesion molecules are also important in that they act as a binding site 
for the leukocytes in the blood vessels at the site of infection. Therefore the 
production of IL-8 and MCP-1 as well as ICAM-1 by HUVEC following exposure 
with different chlamydia serovars was investigated.  
 
Amongst all LGV strains, L3 was the only serovar which stimulated significantly 
higher amount of IL-8, MCP-1 and ICAM-1 in HUVEC compared to the negative and 
mock infected controls. Focusing on C. pneumoniae, former studies used L2 as a 
representative strain for the LGV biovar and hence conclude that all LGV strains do 
not induce chemokine and adhesion molecule production. They then reach a 
conclusion that up regulation of these pro-inflammatory factors is unique to C. 
pneumoniae. For instance, a study by Molestina et al. in 1999 demonstrated that L2 
failed to stimulate production of IL-8 and MCP-1 after 24 hours of incubation 
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whereas the C. pneumoniae strains did. Another study by Krüll et al. (2004) also used 
L2 and showed that after 24 hours of incubation L2 was able to infect HUVEC but did 
not stimulate any production of IL-8 and MCP-1. Once again C. pneumoniae strains 
were able to induce production of chemokines hence it was concluded that it is an 
attribute unique to this species.  
 
Our results correlate with the above authors’ studies in that L2 did not induce 
production of IL-8, MCP-1and ICAM-1 after 24 hours of incubation. The same was 
observed with serovar L1. However unlike other studies we also included L3. There is 
no literature on effect of L3 on HUVEC in terms of up regulation of proinflammatory 
factors. 
 
C. trachomatis strains are grouped into biovars based on differences in clinical 
presentation which correlates with differences of the MOMP and serological 
differences in OMP-A and sequence differences of the ompA gene (Wang and 
Grayston, 1974). Attempts to relate the MOMP structure to virulence have been 
unsuccessful. It has been hypothesised that immune pressure causes MOMP 
variability hence strain differences but so far there has been no successful studies 
done to validate this (Byrne, 2010).   
 
Extensive phylogenetic analysis done on the sequence of the ompA gene showed 
some interesting results. It was found that even though L1 and L2 belonged to the 
same genotype cluster, L3 did not belong to this cluster (Fitch et al., 1993). This 
might explain the different behaviour observed by L3 in this study. From this follows 
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the possibility that virulence factors which are responsible for inflammation within 24 
hours are produced by L3 which the other two strains do not have.  
 
Virulence factors attributed to C. trachomatis virulence include the following: Type 
III chlamydial secretion proteins responsible for presenting the bacterial effector 
proteins to the host (Cornelis and Van Gijsegem, 2000), the polyphormic 
outermenbrane proteins (pmps), which act as autotransporters (Stephens et al., 1998), 
the putative chlamydial cytotoxin, stress response proteins and the cryptic plasmid 
(Byrne, 2010). However more work need to be done to relate these factors to strain 
variation in virulence and classification (Byrne, 2010). Another possibility might be 
that even though the LGV serovars cause the same damage.i.e. lymphadenitis, maybe 
they achieve this by means of different pathogenetic mechanisms. L3 might induce 
inflammation earlier than L1 and L2, and through a different pathway.  
 
Another factor that could explain the observed differences between LGV serovars is 
loss of virulence during passaging the organisms in in-vitro culture systems. The 
passage number of the strains we used is unknown but these are old laboratory strains. 
Since L2 is used in most laboratory studies, it can be assumed that that strain has a 
higher passage number than the others. The possibility that L3 is the one with the 
lowest passage number can not be excluded. 
 
The differences between the serovars reported here could relate to differences in 
pathogenicity. However, no difference in clinical presentation has been observed. 
Joubert and Sturm (2011) reported on the difference in behaviour between the L2 
reference strain and clinical isolates of the same serovar. They conclude that 
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observations made with reference strains might not be representative for hostcell-
chlamydia interaction. This conclusion was reached when the work presented here 
had been completed. The work will be extended with fresh clinical isolates as a 
separate project.  
 
After 24 hours of incubation, there was no difference in up regulation of IL-8, MCP-1 
and ICAM-1 between the LGV serovar L1-L2 and the OG serovar E. L3 was the only 
LGV serovar which stimulated the pro-inflammatory proteins. L1 and L2 might 
behave similarly because they fall phylogenetically in the same ompA sequence 
cluster. Interestingly, serovar E was grouped with L1 and L2 which might explain 
why there was no difference between these serovars. This correlates with studies by 
Molestina et al. (1998), who showed that both serovar E and L2 did not induce 
significant production of IL-8 and MCP-1 after 24 hours of HUVEC infection. 
However, it must be noted that although no differences were observed between L1, 
L2 and E after 24 hours, this does not necessarily mean that there would not be any 
differences with increase in time. It is possible that with increasing time there might 
be distinct differences between LGV and OG biovars because they have different 
disease outcome. Further studies should be done based looking at the effect of 
different serovars on HUVEC with increasing time. 
 
L3 had the highest chemotactic effect on monocytes which correlates with MCP-1 
induction experiments. L1, L2 and E did not stimulate any significant migration of 
monocytes compared to the mock infected cells, which correlates with lack of 
significant induction of MCP-1 by these serovars. There was no significant 
stimulation of migration of neutrophils as compared to the negative and mock infected 
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controls by all the chlamydia serovars. However despite not being significant, L3 has 
the most positive effect on neutrophil migration and this is in keeping with its 
stimulation of IL-8 production by HUVEC. Molestina et al., 1998 showed a slight 
increase in neutrophil migration on exposure to L2 and a significant induction of 
transendothelial migration of monocytes despite lack of MCP-1 production. Our 
results confirm these observations. 
 
Serovar E had the least migratory effect for both monocytes and neutrophils; the 
number of migrated neutrophils was the same as with the mock infected HUVEC. 
Thus after 24 hours of infection the LGV serovars do stimulate more recruitment and 
transendothelial migration of monocytes and neutrophils as compared to the OG 
serovar. This is in keeping with the more severe acute inflammation as seen clinically.  
 
The transendothelial migration assay results could not be tested for normality because 
they were only three values for each experiment instead of nine. The assay was labour 
intensive and long and hence could not be done in triplicates in a day by one person 
without compromising the outcome due to technical errors. Monocytes and 
neutrophils also had to be isolated from the blood on the same day of experiment and 
not more than two runs could be done at once.  It was therefore decided to do one well 
per serovar for monocytes and neutrophil transendothelial migration. 
 
The lactate dehydrogenase (LDH) cytotoxicity assay was used to measure cell death 
due to necrosis of HUVEC infected with different C.trachomatis serovars after 24 
hours of infection. Host cell lysis has been shown to be a mechanisms used by C. 
trachomatis elementary bodies to leave the infected cell (Todd and Caldwell, 1985). 
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Moulder et al. (1976) have also reported a damaging cytotoxic effect on cells infected 
with C. trachomatis at high MOI (=5). Furthermore, C. trachomatis cytotoxicity has 
been described as early as 1944 by Rake and Jones on macrophages. 
 
 L3 was the only serovar which caused significantly higher percentage of cytotoxicity 
compared to the negative control but not compared with the mock infected cells. The 
rest of the serovars however were not significantly different from all controls. There 
was no significant difference between the LGV serovars and OG serovar. L3 might 
have multiplied more rapidly and started shedding the EBs and hence caused early 
cell lysis. This needs further investigation. Lack of measurable LDH by other serovars 
might mean that they might not have reached a point in their life cycle where they had 
to leave the host cell to infect others. Moulder et al. (1976) reported cytotoxicty at a 
higher MOI (=5). This suggests that indeed, cell lysis is related to the number of 
chlamydia in the cell.  
 
A cytotoxicity associated gene known as clostridial toxin A gene was identified by 
Belland et al. (2001). These authors reported that L2 has a deletion in the region 
where this gene is located. They attributed this to the lack of cytotoxicity of L2 in 
their experiments and reasoned that lack of L2 cytotoxicity on epithelial cells allows it 
to infect monocytes and disseminate to the lymph nodes. This statement has been 
quoted by others and has been extrapolated for all LGV serovars (Byrne, 2010). 
 
C. trachomatis has been reported to have apoptotic and anti apoptotic properties. 
Being an intracellular organism it needs the host cell for survival and thus has 
developed strategies to keep the host cell viable. On the other hand the organism 
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needs to exit the cell to infect other cells and therefore has to kill the cell, possibly 
through inducing apoptosis.  
 
With the TUNEL assay, some small brown apoptotic bodies were observed on the 
negative control and mock infected controls in all experiments (figure 15). These 
bodies are smaller in size compared to the DNase treated positive control. They were 
also seen in uninfected cells in between the infected HUVEC (figure 16 and 17). 
These apoptotic bodies can be attributed to the normal cell turn over since they were 
also observed in the negative control. Cells have been shown to die through apoptosis 
during normal cell development (mitosis and cytokinesis) and tissue homeostasis, 
inorder to maintain stable cell population in the body (Lockshin and Zakeri, 2004; 
Steller, 1995). The nucleus of these cells normally shrinks and condenses whereas the 
membrane still remains intact (Lockshin and Zakeri, 2004; Steller, 1995). The small 
brown apoptotic bodies observed in our setting are typical of these fragments. 
 
Analysis of the infected cell by counterstaining TUNEL staining with C. trachomatis 
staining test revealed no apoptotic positive nuclei in the infected cells. This was 
common in all the LGV and OG C. trachomatis infected cells. However, where the 
infected cell was positioned, a faint brown colour was observed. This might mean that 
the infected cell was in a process of dying and the nucleus was starting to fragment. It 
has been shown that cells infected with chlamydia resist apoptosis until they have 
completed their intracellular cycle prolonging the life of the cell they inhabit (Dean 
and Powers, 2001). This anti-apoptotic activity is attributed to the up regulation of the 
bcl-2 gene by C. trachomatis during the reticulate body stage thus inhibiting apoptosis 
during the first 24 hours of infection (Dean and Powers, 2001). In this study cells 
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were only incubated for 24 hours hence the anti-apoptotic systems were still in place.  
Apoptosis of infected cell might have occurred with increase in incubation time as the 
reticulate bodies transform into elementary bodies hence down regulation of the bcl-2 
gene.  
The TUNEL assay has been criticised for not being able to discriminate between 
necrotic cells which have gone through DNA laddering and apoptotic cells (Grasl-
Kraupp et al., 1995; de Torres et al., 1997). This assay was chosen for this study 
because it made it able for the infected cells to also be counterstained with the C. 
trachomatis confirmation stain to provide evidence that the cells were indeed infected. 
 
To further confirm whether cell death on chlamydia infected HUVEC was by 
apoptosis or some other mechanism, the CaspGlow Flurescein Caspase Staining assay 
was performed. This assay is thought to be specific in that it binds to activated 
capsases. There seemed to be no difference between the uninfected negative control, 
mock infected control and LGV and OG serovars infected HUVEC. This supports 
what was observed with the TUNEL assay.  
 
The disadvantage of this method was that it did show apoptotic cells clusters in one 
part of the slide and not in others. Hence counting of stained cells in different field of 
view could not be carried out. This might have been due by the observation that 
conjugating caspase inhibitors with peptide markers which mimic the caspase 
cleavage sites leads to non-specific inhibition due to overlapping of caspase activity 
since this assay also has an inhibitor (VAD-FMK) bound to a marker (FITC) 
(Thornberry et al., 1997; Villa et al., 1997). This assay measures the enzyme activity 
in a population of cells and not in a single cell (Vermes et al., 2000). The authors 
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suggest that flow cytometry can be used interrogate individual cells which was not 
employed in our setting. 
 
It must be noted that some other types of postulated cell death mechanisms such 
pyroptosis, autophagy and oncosis may be involved. However, there are no 
established laboratory techniques as yet to measure them. Some researchers have 
stipulated that cell death may involve numerous pathways and communication 
between the pathways allows for a controlled form of death. They postulate that no 
distinct cell death programme is responsible for the death of a cell, but that there is an 
overlap of several cell death pathways (Ankarcrona et al., 1995; Kostin et al., 2003; 
















CHAPTER 6: CONCLUSION 
 
Our results show that all the LGV and OG C.trachomatis serovars are able to infect 
and replicate in HUVEC. However only L3 was able to stimulate significant levels of 
proinflammatory factors (IL-8, MCP-1 and ICAM-1) and stimulated migration of the 
highest number of monocytes and neutrophils compared to other serovars after 24 
hours of incubation. Comparison of LGV and OG serovars showed no significant 
difference between these two biovars in inducing production of IL-8 and MCP-1, but 
L3 stimulation of ICAM-1 was significantly higher than E. Cell death by necrosis was 
only significant in cells infected by L3 serovar. Serovar L3 seems to stimulate a more 
rapid acute immune response compared to the other serovars. The rest of the LGV 
serovars do not differ from the OG serovar E in inducing inflammation in the first 24 
hours of infection.There was no evidence of cell death by apoptosis due to any 
chlamydial serovar supporting studies by Gupta, 2001 that chlamydia activates the 
anti-apoptotic Bcl-2 gene to inhibit apoptosis of the infected cell so that it can 
complete its intracellular life cycle. Further studies need to be done to compare these 
serovars activation and infect in/ on HUVEC at different time intervals (increasing 
time). Studies with fresh clinical isolates need to follow to rule out the effect of 
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APPENDIX A – Tissue culture reagents and media 
 
McCoy freezing Fluid 
Per 100 ml: 
30 ml EMEM 
10 ml FBS 
10 ml DMSO (Fluka, Steinheim, Germany) 
 
To a 100 ml autoclaved bottle add 30 ml of EMEM, 10 ml of FCS and lastly 10 ml of 
DMSO and swirl gently to mix. Filter sterilise the freezing fluid. Aliquot the freezing 
fluid onto 10 ml tubes, seal tightly and store in a -20 °C freezer. This must be done 
under sterile conditions in a safety cabinet. Volumes of the reagents can be altered 
according to how much of the freezing fluid is needed. 
 
Chlamydia Growth Media/ Inoculation Media 
10% FBS 
2mM L-Glutamine 
1% Non-essential amino acids 
4mg of glucose per ml 
10mM HEPES 
10µg of gentamicin per ml 
10µg of cycloheximide per ml 
10µg of fungizone per ml 
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Add all the above reagents to EMEM with Non essential amino acids (NEAA), 
Earle’s balanced salt solution (EBSS) to yield their stated concentrations. 
 
HUVEC freezing fluid 
Per 40ml: 
30 ml of reconstituted EGM-2 media  
5 ml FBS 
5 ml of DMSO 
 
Add 5 ml of FBS and 5 ml of DMSO to the EGM-2 media. Filter sterile the fluid 
through a 0.22 µm filter, aliquot and store at -4°C until required. 
 
Phosphate Buffered Saline (PBS) solution 
5 PBS tablets (Oxoid) 
500ml distilled water 
 
Add the 5 PBS tablets to a 500 ml sterile bottle containing 500 ml of autoclaved triple 
distilled water. Allow the tablets to dissolve and then sterilize the solution by 
autoclaving at 121°C for 10 minutes. Aliquot into 20ml tubes and store in a -20°C 
freezer until use.  
 
Sucrose-Phosphate-Glutamate Buffer (SPG) buffer 
0.260g KH2PO4  
0.7645g Na2HPO4.7H2O  
37.5g sucrose  
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0.360g glutamic acid  
500 ml distilled water (500ml) 
 
Dissolve the above reagents in 400 ml distilled water. Adjust the pH of the buffer to 
7.5 using the 7.5% sodium bicarbonate. After reaching the target pH adjust the 
volume of the buffer to 500ml using the remaining distilled water.
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APPENDIX B – Objective lens Conversion factors 
These are conversion factors for the objective lens of the fluorescence microscope 
used to determine the concentration of the stored bacterium inoculum. To calculate 
this, the objective lens area is needed.  
The objective lens conversion factors were calculated by dividing the area of the well 








40X 1 600 
100X 10 000 
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This must be prepared just before use and cannot be kept for further experiments. Add 
0.5 ml of HRP diluent to the vial containing Streptavidin-HRP to make a 1:100 
APPENDIX C - Preparation of Reagents for ELISA 
 
IL-8 ELISA Reagents 
 
Wash buffer 
Pipette 2.5 ml of Wash buffer concentrate (200X) into a clean 500 ml graduated 
cylinder. Bring the final volume to 500 ml with triple distilled water. 
Mix gently to avoid foaming. 
 
Standard diluent buffer 




Reconstitute the standard by adding the volume of standard diluent buffer stated on 
the label of the standard vial. 
 
Biotinylated anti-IL-8 
Dilute 120 µl of biotinylated antibody concentrate with 3, 180 ml of biotinylated 




dilution. Make a further dilution with HRP-diluent in a clean glass vial as needed in 
this case mix 75 µl of pre-diluted Streptavidin-HRP with 5 ml of HRP diluent 
 
MCP-1 ELISA Reagents 
 




Add 25 ml of wash buffer concentrate with into a clean 500 ml graduated cylinder and 
bring the final volume to 500 ml with triple distilled water. Gently mix to avoid 
foaming. Measure the pH to confirm that its 7.4. 
 
Assay buffer 
Shake the Assay buffer concentrate gently to ensure proper mixture of the contents 
Pipette 2.5 ml of the assay buffer concentrate to 47.5 ml of triple distilled water. 
Gently mix to avoid foaming 
 
MCP-1 Standards 
Reconstitute the lyophilized standard with distilled water as stated on the standard vial 
label. Mix gently until the contents have dissolved. 
 
HRP-Conjugate 
Mix 0.03 ml of HRP-Conjugate with 2.97 ml of Assay buffer in a clean plastic test 
tube to make 1:100 dilution. 
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Addition of Colour-giving reagents: Blue Dye, Green Dye 
Before sample dilution add 200 µl of Blue dye to 50 ml of assay buffer (1:250 
dilution). Before dilution of the concentrated conjugate add 30 µl of the Green-Dye to 
3 ml of the assay buffer used for the final conjugate dilution (1:100 dilution). 
 
ICAM ELISA Reagents 
 
1% formaldehyde 
Add 17 ml of PBS (pH 7.4, Oxoid) to a 20ml tube and then add 0.5ml of 35% 
formaldehyde. Swirl gently to mix. 
 
50µg/ml anti-ICAM 
Reconstitute the 500µg anti-humanICAM-1 purified mouse monoclonal IgG1 to a 
stock concentration of 0.5mg/ml by adding 1ml of sterile PBS (pH 7.4, Oxoid). Store 
in a -20°C until further use .Before starting the assay get the reconstituted anti-
hICAM from the freezer and allow it to come to room temperature. To 5 ml of sterile 
PBS (pH 7.4, Oxoid) in a 15 ml tube add 0.5µl of the reconstituted anti-ICAM. Swirl 
gently to mix.  
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 IL-8 Production by HUVEC, optical density (pg/ml), calculated concentration and concentration per 100ml 
 
L1 L2  L3 E TNFα McCoy HUVEC Only 
  OD Conc. Conc. L2 Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. 
    (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100 
Exp 1 2.044 1437.5 0.299 1.799 1233.3 0.257 2.646 1939.2 0.404 2.19 1559.2 0.325 2.072 1460.83 0.304 1.933 1345 0.28 1.913 1328.3 0.27674 
  1.987 1390 0.29 1.648 1107.5 0.231 2.014 1412.5 0.294 2.223 1586.7 0.331 1.991 1393.33 0.29 1.935 1346.7 0.281 1.626 1089.2 0.22691 
  1.693 1145 0.239 1.834 1262.5 0.263 2.662 1952.5 0.407 2.024 1420.8 0.296 2.646 1939.17 0.404 2.003 1403.3 0.292 1.999 1400 0.29167 
Exp 2 1.863 1337.6 0.248 2.195 1603.2 0.297 3.005 2251.2 0.417 2.19 1599.2 0.296 2.089 1518.4 0.281 1.632 1152.8 0.213 1.752 1248.8 0.23126 
  2.27 1663.2 0.308 1.904 1370.4 0.254 2.668 1981.6 0.367 2.019 1462.4 0.271 2.402 1768.8 0.328 2.029 1470.4 0.272 1.907 1372.8 0.25422 
  1.748 1245.6 0.231 1.991 1440 0.267 2.764 2058.4 0.381 2.094 1522.4 0.282 1.856 1332 0.247 1.492 1040.8 0.193 1.578 1109.6 0.20548 
Exp 3 2.101 1383.8 0.216 1.814 1172.8 0.183 3.244 2224.3 0.348 1.94 1265.4 0.198 3.377 2322.06 0.363 2.078 1366.9 0.214 1.577 998.53 0.15602 
  1.869 1213.2 0.19 1.692 1083.1 0.169 2.585 1739.7 0.272 2.154 1422.8 0.222 3.377 2322.06 0.363 1.921 1251.5 0.196 2.038 1337.5 0.20898 
  2.991 2038.2 0.318 2.056 1350.7 0.211 3.378 2322.8 0.363 2.051 1347.1 0.21 3.377 2322.06 0.363 1.794 1158.1 0.181 1.804 1165.4 0.1821 
Mean     0.26     0.237     0.361     0.27     0.327     0.236     0.22593 
STDEV     0.043     0.039     0.047     0.046     0.047     0.042     0.04116 
N     9     9     9     9     9     9     9 
SEM     0.014     0.013     0.015     0.014     0.014     0.016     0.01372 







 MCP-1 Production by HUVEC, optical density (pg/ml), calculated concentration and concentration per 100ml 
 
L1 L2  L3 E TNFα McCoy HUVEC Only 
  OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. OD Conc. Conc. 
    (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100   (pg/ml) /100 
Exp 1 0.308 152.22 0.0317 0.274 133.33 0.0278 0.475 245 0.051 0.341 170.56 0.0355 0.344 172.22 0.036 0.282 137.78 0.029 0.16 69.444 0.0145 
  0.23 108.89 0.0227 0.273 132.78 0.0277 0.334 166.67 0.0347 0.425 217.22 0.0453 0.624 327.78 0.068 0.202 93.333 0.019 0.35 172.78 0.036 
  0.269 130.56 0.0272 0.299 147.22 0.0307 0.33 164.44 0.0343 0.318 157.78 0.0329 0.527 273.89 0.057 0.479 247.22 0.052 0.4 202.78 0.0422 
Exp 2 0.473 334.79 0.062 0.327 222.48 0.0412 0.173 104.02 0.0193 0.3 201.72 0.0374 0.47 332.48 0.062 0.181 110.18 0.02 0.11 54.023 0.01 
  0.352 241.72 0.0448 0.279 185.56 0.0344 0.284 189.41 0.0351 0.287 191.72 0.0355 0.673 488.64 0.09 0.218 138.64 0.026 0.22 141.72 0.0262 
  0.145 82.485 0.0153 0.226 144.79 0.0268 0.568 407.87 0.0755 0.322 218.64 0.0405 0.552 395.56 0.073 0.244 158.64 0.029 0.26 169.41 0.0314 
Exp 3 0.217 182.56 0.0285 0.227 193.67 0.0303 0.417 404.78 0.0632 0.267 238.11 0.0372 0.46 452.56 0.071 0.258 228.11 0.036 0.1 49.222 0.0077 
  0.327 304.78 0.0476 0.275 247 0.0386 0.377 360.33 0.0563 0.233 200.33 0.0313 0.594 601.44 0.094 0.226 192.56 0.03 0.16 115.89 0.0181 
  0.36 341.44 0.0534 0.295 269.22 0.0421 0.499 495.89 0.0775 0.295 269.22 0.0421 0.563 567 0.089 0.22 185.89 0.029 0.18 142.56 0.0223 
Mean     0.037     0.0333     0.0497     0.0375     0.071     0.03     0.0232 
STDEV     0.0147     0.0057     0.0191     0.0042     0.017     0.009     0.0112 
N     9     9     9     9     9     9     9 
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 Optical density of ICAM-1 produced by HUVEC infected with C. 
trachomatis serovars and controls, measured at 450nm. 
 
L1 L2 L3 E 
 
TNFα McCoy HUVEC only 
Exp 1 1.125 0.79 0.877 0.971 1.189 0.729 1.084 
  0.79 0.711 1.253 1.126 1.202 0.963 0.744 
  0.853 0.799 0.864 0.649 1.153 0.946 0.877 
Exp 2 0.981 1.017 1.562 0.944 1.116 0.655 0.755 
  1.096 0.999 1.088 0.9 1.272 0.831 0.812 
  1.113 0.933 1.291 0.877 1.124 0.816 0.956 
Exp 3 0.839 0.756 0.971 0.854 1.14 0.798 0.793 
  1.028 0.79 0.923 0.931 1.277 0.812 0.917 
  0.857 0.844 0.855 0.84 1.243 0.857 0.791 
Mean 0.964667 0.848778 1.076 0.899111 1.190667 0.823 0.858777778 
STDEV 0.124543 0.102718 0.231352 0.119375 0.058636 0.090556 0.104855221 
N 9 9 9 9 9 9 9 



































 Raw data absorbance readings measured at 450nm for the LDH Cytotoxicity assay of HUVEC infected with different C. trachomatis 
LI, L2, L3 and E, also included are the controls. 
 
 
L1 L2 L3 E TNFα McCoy HUVEC 
Cell 
max.  Volume  Spontaneous.  Culture  
              only  LDH  Correction release  medium 
                release control control control 
Exp 1 0.293 0.275 0.462 0.408 0.556 0.275 0.422 0.767 0.145 0.161 0.164 
  0.362 0.29 0.484 0.381 0.381 0.352 0.36 0.772 0.145 0.171 0.147 
  0.41 0.465 0.473 0.476 0.422 0.345 0.313 0.65 0.132 0.228 0.132 
Exp 2 0.429 0.419 0.555 0.458 0.649 0.481 0.486 0.844 0.159 0.142 0.105 
  0.41 0.432 0.65 0.377 0.427 0.387 0.456 0.742 0.122 0.104 0.102 
  0.48 0.446 0.514 0.406 0.723 0.408 0.277 0.856 0.144 0.132 0.11 
Exp 3 0.455 0.607 0.648 0.378 0.63 0.456 0.445 1.086 0.12 0.107 0.112 
  0.419 0.521 0.587 0.58 0.597 0.455 0.615 0.999 0.119 0.107 0.116 















 Values after subtraction of Culture Medium control, background control and 
average absorbance values from experimental wells from the LDH Cytotoxicity assay. 
 
L1 L2 L3 E TNFα McCoy 
HUVEC 
Only 
Exp 1 0.144 0.126 0.313 0.259 0.407 0.273 0.126 
  0.213 0.141 0.335 0.232 0.232 0.211 0.203 
  0.261 0.316 0.324 0.327 0.234 0.164 0.196 
Exp 2 0.323 0.313 0.449 0.352 0.543 0.375 0.38 
  0.304 0.326 0.544 0.271 0.321 0.281 0.349 
  0.374 0.34 0.408 0.3 0.617 0.302 0.171 
Exp 3 0.343 0.495 0.536 0.266 0.518 0.344 0.343 
  0.307 0.409 0.475 0.468 0.485 0.343 0.503 







 Calculated % Cytotoxicity of different chlamydia serovars 
 
 
L1 L2 L3 E TNFα McCoy 
HUVEC 
Only 
Exp 1 19.2922 16.02541 49.9637 40.16334 67.02359 42.70417 16.02540835 
  31.81488 18.74773 53.95644 35.26316 35.26316 31.45191 30 
  40.52632 50.50817 51.96007 52.50454 35.62613 22.92196 28.72958258 
Exp 2 44.06442 42.53067 63.38957 48.51227 77.80675 52.03988 52.80674847 
  41.15031 44.52454 77.96012 36.08896 43.75767 37.6227 48.05214724 
  51.8865 46.67178 57.10123 40.53681 89.15644 40.84356 20.75153374 
Exp 3 40.89806 59.34466 64.32039 31.5534 62.13592 41.01942 40.89805825 
  36.52913 48.90777 56.91748 56.06796 58.13107 40.89806 60.31553398 
  32.76699 61.16505 54.73301 40.04854 76.69903 54.61165 53.03398058 
Mean 37.65876 43.15842 58.92245 42.30433 60.6222 40.45703 38.95699924 
STDEV 8.63491 14.98144 8.095329 7.807463 18.16513 9.048203 14.8128252 
N 9 9 9 9 9 9 9 


















 Number of cells migrated during the transendothelial migration assay, cell 
count done with the haemacytometer and trypan blue dye. 
 
Neutrophils Monocytes 
  Exp 1 Exp 2 Exp 3 Exp 1 Exp 2 Exp 3 
L1 4 5 6 3 3 4 
L2 5 5 3 4 3 5 
L3 6 7 4 5 4 4 
E 3 4 4 2 1 4 
TNFα 11 14 8 7 6 5 
McCoy 4 5 2 1 2 2 
HUVEC 






 Calculated number of migrated cells from the cell count 
 
Neutrophils Monocytes 
  Exp 1 Exp 2 Exp 3 AVG Exp 1 Exp 2 Exp 3 AVG 
L1 12000 15000 18000 15000 9000 9000 12000 10000 
L2 15000 15000 9000 13000 12000 9000 15000 12000 
L3 18000 21000 12000 17000 18000 12000 12000 14000 
E 9000 12000 12000 11000 6000 3000 12000 7000 
TNFα 33000 39000 24000 32000 21000 18000 15000 18000 
McCoy 12000 15000 6000 11000 3000 6000 6000 5000 
HUVEC 

























APPENDIX E: Statistical Analysis 


























Intercellular Cell Adhesion Molecule-1 Statistical analysis 
 
 
One-way Analysis of Variance (ANOVA)                
The P value is 0.0057, considered very significant. 
Variation among column means is significantly greater than expected 
by chance. 
Tukey-Kramer Multiple Comparisons Test 
If the value of q is greater than 4.204 then the P value is less 
than 0.05. 
                                                Mean    
            Comparison             Difference          q                P value   
================    ==========   =======   ==========  
             L1 vs L2                    0.1159       2.388 ns            P>0.05 
             L1 vs L3                  -0.1113       2.294 ns            P>0.05 
             L1 vs E                     0.06556      1.351 ns            P>0.05 
             L1 vs McCoy            0.1417       2.919 ns            P>0.05 
             L1 vs HUVEC only  0.1059       2.182 ns            P>0.05 
             L2 vs L3                  -0.2272       4.682  *             P<0.05 
             L2 vs E                    -0.05033     1.037 ns            P>0.05 
             L2 vs McCoy            0.02578     0.5312 ns          P>0.05 
             L2 vs HUVEC only -0.01000    0.2061  ns          P>0.05 
             L3 vs E                      0.1769      3.645  ns            P>0.05 
             L3 vs McCoy             0.2530      5.214  **           P<0.01 
             L3 vs HUVEC only   0.2172     4.476  *              P<0.05 
              E vs McCoy              0.07611   1.568  ns             P>0.05 
              E vs HUVEC only    0.04033    0.8312  ns          P>0.05 
          McCoy vs HUVEC only-0.03578 0.7373 ns           P>0.05 
 
                                              Mean    95% Confidence Interval 
 
            Difference             Difference    From        To    
           ===========   ==========   ======  ===== 
             L1 - L2                   0.1159     -0.08814     0.3199 
             L1 - L3                  -0.1113     -0.3154      0.09269 
             L1 - E                   0.06556     -0.1385       0.2696 
             L1 - McCoy           0.1417      -0.06236     0.3457 
             L1 - HUVEC only   0.1059    -0.09814     0.3099 
             L2 - L3                  -0.2272     -0.4312      -0.02320 
             L2 - E                  -0.05033     -0.2544        0.1537 
             L2 - McCoy          0.02578     -0.1782        0.2298 
             L2 - HUVEC only  -0.01000  -0.2140        0.1940 
             L3 - E                    0.1769       -0.02714      0.3809 
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             L3 - McCoy         0.2530          0.04898       0.4570 
             L3 - HUVEC only   0.2172      0.01320       0.4212 
              E - McCoy          0.07611           -0.1279     0.2801 
              E - HUVEC only     0.04033     -0.1637      0.2444 
          McCoy - HUVEC only -0.03578  -0.2398      0.1682 
 
Assumption test: Are the standard deviations of the groups equal? 
 
ANOVA assumes that the data are sampled from populations with identical SDs. This 
assumption is tested using the method of Bartlett. 
Bartlett statistic (corrected) = 10.522 
The P value is 0.0617.  
Bartlett's test suggests that the differences among the SDs is not quite significant. 
Assumption test: Are the data sampled from Gaussian distributions? 
ANOVA assumes that the data are sampled from populations that follow Gaussian 
distributions. This assumption is tested using the method  
Kolmogorov and Smirnov: 
     Group        KS     P Value  Passed normality test? 
======= ===== ======   =============== 
             L1   0.2369     >0.10     Yes 
             L2   0.2317     >0.10     Yes 
             L3   0.2212     >0.10     Yes 
              E    0.2092     >0.10     Yes 
       McCoy  0.1751  >0.10        Yes 
HUVEC only0.2185 >0.10       Yes 
 
Intermediate calculations. ANOVA table 
 
        Source of                           Degrees of      Sum of        Mean   
        variation                              freedom       squares        square  
============================  ==========  ========   
Treatments (between columns)         5            0.4013           0.08025 
Residuals (within columns)            48            1.017              0.02119 
----------------------------  ----------  -------- 
Total                                                   53         1.419 
 






                                        Summary of Data                          
                     Number                                 Standard 
                         of                       Standard   Error of 
     Group      Points     Mean   Deviation    Mean     Median  
  =======  ======= ======  ====== =========  ========   
             L1         9       0.9647      0.1321       0.04403        0.9810 
             L2         9       0.8488      0.1089       0.03632        0.7990 
             L3         9       1.076        0.2454       0.08180        0.9710 
              E          9       0.8991      0.1266       0.04221        0.9000 
       McCoy       9       0.8230      0.09605      0.03202        0.8160 
HUVEC only    9       0.8588      0.1112        0.03707        0.8120 
 
                                  
                              95% Confidence Interval 
     Group      Minimum   Maximum     From        To     
   =======  ======= ======== ======== ========== 
             L1       0.7900       1.125          0.8631      1.066 
             L2       0.7110       1.017          0.7650     0.9325 
             L3       0.8550       1.562          0.8874      1.265 
              E        0.6490       1.126          0.8018     0.9964 
      McCoy      0.6550        0.9630        0.7492     0.8968 


































              One-way Analysis of Variance (ANOVA)                
The P value is 0.1642, considered not significant. 
Variation among column means is not significantly greater than expected by chance. 
Post tests 
Post tests were not calculated because the P value was greater than 0.05. 
Assumption test: Are the standard deviations of the groups equal? 
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett. 
Bartlett's test can only be performed when every column has at least five values. 
Assumption test: Are the data sampled from Gaussian distributions? 
ANOVA assumes that the data are sampled from populations that follow Gaussian 
distributions. This assumption is tested using the method  
Kolmogorov and Smirnov: 
 
     Group        KS     P Value  Passed normality test? 
=============== ======   ======== ======================= 
             L1   Too few values to test. 
             L2   Too few values to test. 
             L3   Too few values to test. 
              E   Too few values to test. 
          McCoy   Too few values to test. 




Intermediate calculations. ANOVA table 
 
        Source of                                          Degrees of Sum of     Mean   
        variation                                            freedom    squares    square  
============================  ========  ======  ======== 
Treatments (between columns)                    5             1.105        2.210 
Residuals (within columns)                        12             1.380       1.150 
----------------------------  ----------  -------- 
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Total                                                            17             2.485 
 
F = 1.922 = (MStreatment/MSresidual)  
 
 
                         Summary of Data                          
 
                     Number                    Standard 
                         of       Standard      Error of 
     Group      Points     Mean       Deviation    Mean     Median  
=======  ====== ======   ======== =========  ========   
         L1          3        15000        3000.0        1732.1          15000 
         L2          3        13000        3464.1        2000.0          15000 
         L3          3        17000        4582.6        2645.8          18000 
          E           3        11000        1732.1        1000.0          12000 
       McCoy     3       11000        4582.6         2645.8          12000 
  HUVEC only 3      10000        1732.1        1000.0             9000.0 
 
                                  95% Confidence Interval 
         Group           Min         Max      From        To     
     ========   ====== =====   ====== =========  
             L1         12000      18000     7547.0      22453 
             L2          9000.0    15000     4394.0      21606 
             L3         12000      21000     5615.3      28385 
              E           9000.0    12000     6697.0      15303 
        McCoy       6000.0    15000    -384.67      22385 
     HUVEC only 9000.0   12000     5697.0      14303 
 
 





              One-way Analysis of Variance (ANOVA)                
The P value is 0.0069, considered very significant. 
Variation among column means is significantly greater than expected by chance. 
Tukey-Kramer Multiple Comparisons Test 





                                                Mean    
            Comparison             Difference    q      P value   
================================== ========== =======  
             L1 vs L2                   -2000.0   1.188  ns  P>0.05 
             L1 vs L3                   -4000.0   2.376  ns  P>0.05 
             L1 vs E                      3000.0   1.782  ns  P>0.05 
             L1 vs McCoy            5000.0   2.970  ns   P>0.05 
             L1 vs HUVEC only  6000.0   3.565  ns   P>0.05 
             L2 vs L3                  -2000.0   1.188  ns   P>0.05 
             L2 vs E                     5000.0   2.970  ns   P>0.05 
             L2 vs McCoy            7000.0   4.159  ns   P>0.05 
             L2 vs HUVEC only  8000.0   4.753  *    P<0.05 
             L3 vs E                     7000.0   4.159  ns   P>0.05 
             L3 vs McCoy            9000.0   5.347  *    P<0.05 
             L3 vs HUVEC only10000      5.941  *    P<0.05 
              E vs McCoy             2000.0   1.188  ns   P>0.05 
              E vs HUVEC only   3000.0   1.782  ns   P>0.05 
      McCoy vs HUVEC only1000.0    0.5941 ns   P>0.05 
 
                                               Mean    95% Confidence Interval 
            Difference             Difference   From     To    
========================== ======= ===== 
             L1 - L2                  -2000.0    -9997.1   5997.1 
             L1 - L3                  -4000.0    -11997    3997.1 
             L1 - E                     3000.0    -4997.1   10997 
             L1 - McCoy           5000.0     -2997.1   12997 
     L1 - HUVEC only         6000.0     -1997.1   13997 
             L2 - L3                 -2000.0     -9997.1    5997.1 
             L2 - E                    5000.0     -2997.1   12997 
             L2 - McCoy           7000.0     -997.12   14997 
     L2 - HUVEC only         8000.0       2.875     15997 
             L3 - E                    7000.0      -997.12   14997 
             L3 - McCoy           9000.0      1002.9   16997 
     L3 - HUVEC only       10000         2002.9   17997 
              E - McCoy             2000.0    -5997.1   9997.1 
      E - HUVEC only           3000.0    -4997.1   10997 
      McCoy - HUVEC only 1000.0    -6997.1   8997.1 
 
Assumption test: Are the standard deviations of the groups equal? 
ANOVA assumes that the data are sampled from populations with identical SDs. This 
assumption is tested using the method of Bartlett. 
 
Bartlett's test can only be performed when every column has at least five values. 
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Assumption test: Are the data sampled from Gaussian distributions? 
ANOVA assumes that the data are sampled from populations that follow  
Gaussian distributions. This assumption is tested using the method  
Kolmogorov and Smirnov: 
 
     Group        KS     P Value  Passed normality test? 
=============== ======   ======== ======================= 
             L1   Too few values to test. 
             L2   Too few values to test. 
             L3   Too few values to test. 
              E   Too few values to test. 
          McCoy   Too few values to test. 
     HUVEC only   Too few values to test. 
 
Intermediate calculations. ANOVA table 
 
        Source of                                          Degrees of       Sum of        Mean   
        variation                                             freedom          squares        square  
============================  ==========     ===== ===== 
Treatments (between columns)                          5                 2.380      4.760 
Residuals (within columns)                              12                1.020     8500000 
----------------------------  ----------  -------- 
Total                                                                 17                                  3.400 
 
F = 5.600 = (MStreatment/MSresidual)  
                                  Summary of Data                          
                       Number                              Standard 
                          of              Standard        Error of 
     Group      Points     Mean   Deviation    Mean      Median  
=============== ======   ======     ====   ======= 
             L1             3       10000   1732.1     1000.0    9000.0 
             L2             3       12000   3000.0     1732.1     12000 
             L3             3       14000   3464.1     2000.0     12000 
              E              3      7000.0   4582.6     2645.8    6000.0 
     McCoy              3      5000.0   1732.1     1000.0    6000.0 






                                  95% Confidence Interval 
     Group      Minimum  Maximum     From        To     
========   =========   ==== ======== ====== 
             L1           9000.0    12000     5697.0     14303 
             L2           9000.0    15000     4547.0     19453 
             L3           12000    18000     5394.0      22606 
              E            3000.0    12000   -4384.7     18385 
          McCoy      3000.0   6000.0     697.00     9303.0 
     HUVEC only 3000.0   6000.0    -303.00     8303.0 
 
 








































LDH cytotoxicity assay statistical analysis 
 
              One-way Analysis of Variance (ANOVA)                
The P value is 0.0004, considered extremely significant. 
Variation among column means is significantly greater than expected 
by chance. 
Tukey-Kramer Multiple Comparisons Test 
If the value of q is greater than 4.329 then the P value is less 
than 0.05. 
 
                                                Mean    
            Comparison             Difference     q            P value   
================   ==========  ===== ==========   
             L1 vs L2                    -5.500      1.266  ns   P>0.05 
             L1 vs L3                    -21.264    4.895  *    P<0.05 
             L1 vs E                      -4.646     1.069  ns    P>0.05 
       L1 vs TNF-alpha           -22.963     5.286  **   P<0.01 
             L1 vs McCoy            -2.798     0.6442  ns  P>0.05 
  L1 vs HUVEC Only            -1.298     0.2989  ns  P>0.05 
             L2 vs L3                 -15.764      3.629  ns    P>0.05 
             L2 vs E                      0.8541     0.1966  ns P>0.05 
             L2 vs TNF-alpha    -17.464      4.020  ns    P>0.05 
             L2 vs McCoy             2.701      0.6219  ns  P>0.05 
  L2 vs HUVEC Only            4.201       0.9672  ns  P>0.05 
             L3 vs E                   16.618       3.825  ns    P>0.05 
             L3 vs TNF-alpha    -1.700       0.3913  ns   P>0.05 
             L3 vs McCoy         18.465       4.251  ns     P>0.05 
  L3 vs HUVEC Only          19.965      4.596  *       P<0.05 
              E vs TNF-alpha    -18.318      4.217  ns     P>0.05 
              E vs McCoy             1.847      0.4252  ns   P>0.05 
              E vs HUVEC Only   3.347     0.7706  ns   P>0.05 
TNF-alpha vs McCoy           20.165    4.642  *       P<0.05 
TNF-alpha vs HUVEC Only 21.665   4.987  *       P<0.05 










                                               Mean    95% Confidence Interval 
            Difference          Difference     From              To    
===============  =========   ======    ======== 
             L1 - L2                  -5.500       -24.305       13.306 
             L1 - L3                -21.264       -40.069       -2.458 
             L1 - E                    -4.646       -23.451      14.160 
             L1 - TNF-alpha   -22.963       -41.769       -4.158 
             L1 - McCoy          -2.798       -21.604       16.007 
     L1 - HUVEC Only       -1.298       -20.104        17.507 
             L2 - L3               -15.764       -34.569          3.041 
             L2 - E                    0.8541      -17.951       19.659 
     L2 - TNF-alpha          -17.464       -36.269          1.342 
             L2 - McCoy           2.701      -16.104         21.507 
     L2 - HUVEC Only        4.201      -14.604         23.007 
             L3 - E                  16.618        -2.187         35.423 
     L3 - TNF-alpha            -1.700      -20.505        17.106 
             L3 - McCoy         18.465       -0.3399       37.271 
     L3 - HUVEC Only      19.965         1.160         38.771 
       E - TNF-alpha          -18.318      -37.123          0.4875 
              E - McCoy            1.847      -16.958        20.653 
        E - HUVEC Only        3.347     -15.458         22.153 
 TNF-alpha - McCoy         20.165       1.360          38.971 
TNF-alpha - HUVEC Only 21.665     2.860          40.471 





Assumption test: Are the standard deviations of the groups equal? 
ANOVA assumes that the data are sampled from populations with identical SDs. This 
assumption is tested using the method of Bartlett. 
Bartlett statistic (corrected) = 11.502 
The P value is 0.0740.  
Bartlett's test suggests that the differences among the SDs is not quite significant. 
Assumption test: Are the data sampled from Gaussian distributions? 
ANOVA assumes that the data are sampled from populations that follow Gaussian 






     Group        KS     P Value      Passed normality test? 
=============== ======   ======== ======================= 
             L1   0.1784      >0.10       Yes 
             L2   0.2620      >0.10       Yes 
             L3   0.2506      >0.10       Yes 
              E    0.2512      >0.10       Yes 
TNF-alpha   0.1426      >0.10       Yes 
     McCoy   0.1852      >0.10       Yes 
HUVEC Only0.1631    >0.10      Yes 
 
Intermediate calculations. ANOVA table 
 
        Source of                              Degrees of   Sum of         Mean   
        variation                               freedom       squares          square  
=====================       ======  ==========  ========   
Treatments (between columns)        6              4971.9         828.65 
Residuals (within columns)            56              9510.8         169.84 
----------------------------  ----------  -------- 
Total                                                 62           14483 
 
F = 4.879  =(MStreatment/MSresidual)  
 
 
                         Summary of Data                          
 
                Number                       Standard 
                  of              Standard   Error of 
     Group      Points     Mean   Deviation    Mean     Median  
   =============== ======   ======== =========  ========  ======== 
             L1          9         37.659    9.159       3.053    40.526 
             L2          9         43.158   15.890      5.297    46.672 
             L3          9         58.922    8.586       2.862    56.917 
              E           9         42.304    8.281       2.760    40.163 
      TNF-alpha    9        60.622   19.267      6.422    62.136 
          McCoy     9         40.457    9.597       3.199    40.898 
   HUVEC Only 9         38.957   15.711      5.237    40.898 
 
                                  95% Confidence Interval 
     Group         Minimum Maximum From        To     
==========  =======  ======   ===== ==========  
             L1           19.292   51.887     30.619     44.699 
             L2           16.025   61.165     30.944     55.373 
             L3           49.964   77.960     52.322     65.523 
              E            31.553   56.068     35.939     48.670 
   TNF-alpha        35.263   89.156     45.812     75.432 
      McCoy           22.922   54.612     33.080     47.834 
  HUVEC Only   16.025   60.316     26.880     51.034 
 
 
                                             *     *     * 
